<SEC-DOCUMENT>0001493152-26-007761.txt : 20260223
<SEC-HEADER>0001493152-26-007761.hdr.sgml : 20260223
<ACCEPTANCE-DATETIME>20260223162531
ACCESSION NUMBER:		0001493152-26-007761
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		21
CONFORMED PERIOD OF REPORT:	20260219
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260223
DATE AS OF CHANGE:		20260223

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ABUNDIA GLOBAL IMPACT GROUP, INC.
		CENTRAL INDEX KEY:			0001156041
		STANDARD INDUSTRIAL CLASSIFICATION:	CRUDE PETROLEUM & NATURAL GAS [1311]
		ORGANIZATION NAME:           	01 Energy & Transportation
		EIN:				760675953
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32955
		FILM NUMBER:		26665602

	BUSINESS ADDRESS:	
		STREET 1:		1300 POST OAK BLVD, SUITE 1305
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77056
		BUSINESS PHONE:		713-322-8818

	MAIL ADDRESS:	
		STREET 1:		1300 POST OAK BLVD, SUITE 1305
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77056

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HOUSTON AMERICAN ENERGY CORP
		DATE OF NAME CHANGE:	20010730
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:AGIG="http://abundiaimpact.com/20260219">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_032_AGIG_abundiaimpact.com_20260219 -->
<!-- Field: Set; Name: xdx; ID: xdx_04E_20260219_20260219 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001156041 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000004" name="dei:EntityCentralIndexKey">0001156041</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="agig-20260219.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2026-02-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001156041</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-02-19</xbrli:startDate>
        <xbrli:endDate>2026-02-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt; text-transform: uppercase"><b>United
States</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_909_edei--DocumentType_c20260219__20260219_zWFrXURwbSi6"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of report (Date of earliest event reported): <span id="xdx_906_edei--DocumentPeriodEndDate_c20260219__20260219_zdv2Jl2gI0Nj"><ix:nonNumeric contextRef="AsOf2026-02-19" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">February 19, 2026</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90B_edei--EntityRegistrantName_c20260219__20260219_zx4J2UfEOcA6"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000011" name="dei:EntityRegistrantName">ABUNDIA
GLOBAL IMPACT GROUP, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20260219__20260219_zKuPXZBgRHie"><ix:nonNumeric contextRef="AsOf2026-02-19" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityFileNumber_c20260219__20260219_zcBQNPR2J4Tb"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000013" name="dei:EntityFileNumber">1-32955</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20260219__20260219_zLVUkDICbsP9"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000014" name="dei:EntityTaxIdentificationNumber">76-0675953</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
    or organization)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
    Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityAddressAddressLine1_c20260219__20260219_zXLYcsUFAjhf"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000015" name="dei:EntityAddressAddressLine1">1300
Post Oak Blvd.</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressAddressLine2_c20260219__20260219_z3blCQm4q8I7"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 1305</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityAddressCityOrTown_c20260219__20260219_zmzvbIUOHJ4j"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000017" name="dei:EntityAddressCityOrTown">Houston</ix:nonNumeric></span>,
<span id="xdx_90F_edei--EntityAddressStateOrProvince_c20260219__20260219_zpEwRjgLvZ1f"><ix:nonNumeric contextRef="AsOf2026-02-19" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Texas</ix:nonNumeric></span> <span id="xdx_901_edei--EntityAddressPostalZipCode_c20260219__20260219_zYNLd8nZBkU1"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000019" name="dei:EntityAddressPostalZipCode">77056</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices, including zip code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--CityAreaCode_c20260219__20260219_z8dYUkzICQ11"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000020" name="dei:CityAreaCode">713</ix:nonNumeric></span>-<span id="xdx_90B_edei--LocalPhoneNumber_c20260219__20260219_zdJUwThDUkQ1"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000021" name="dei:LocalPhoneNumber">322-8818</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&#8217;s
telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--WrittenCommunications_c20260219__20260219_zoNRRd4G7rxd"><ix:nonNumeric contextRef="AsOf2026-02-19" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--SolicitingMaterial_c20260219__20260219_zBCQ6gVG2gT7"><ix:nonNumeric contextRef="AsOf2026-02-19" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--PreCommencementTenderOffer_c20260219__20260219_zlg4Wb55u4Tf"><ix:nonNumeric contextRef="AsOf2026-02-19" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--PreCommencementIssuerTenderOffer_c20260219__20260219_zoiPaDuTUG1h"><ix:nonNumeric contextRef="AsOf2026-02-19" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--Security12bTitle_c20260219__20260219_z3zF7ljnboHf"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000026" name="dei:Security12bTitle">Common
    Stock, par value $0.001 per share</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--TradingSymbol_c20260219__20260219_zpFwAy5LfjZe"><ix:nonNumeric contextRef="AsOf2026-02-19" id="Fact000027" name="dei:TradingSymbol">AGIG</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--SecurityExchangeName_c20260219__20260219_znkcGYOXIG3d"><ix:nonNumeric contextRef="AsOf2026-02-19" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">NYSE
    American</ix:nonNumeric></span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_905_edei--EntityEmergingGrowthCompany_c20260219__20260219_zx8FCm4kUKbi"><ix:nonNumeric contextRef="AsOf2026-02-19" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01. Entry into a Material Definitive Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>On
February 23, 2026, Abundia Global Impact Group, Inc., a Delaware corporation (the &#8220;Company&#8221;), closed an offering pursuant
to that certain Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;), entered into on February 19, 2026, with a certain
institutional investor (the &#8220;Investor&#8221;), pursuant to which the Company agreed to issue and sell, in a registered direct offering
by the Company directly to the Investor (the &#8220;Offering&#8221;), (i) 4,134,175 shares (the &#8220;Shares&#8221;) of common stock,
par value $0.001 per share, of the Company (&#8220;Common Stock&#8221;) and (ii) pre-funded warrants (the
&#8220;Pre-Funded Warrants&#8221;) to purchase up to 1,800,543 shares of Common Stock at an exercise price equal to $0.001 per share.
The Company received gross proceeds of approximately $20.0 million before deducting the placement agent&#8217;s fees and related offering
expenses.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Shares and the Pre-Funded Warrants were offered by the Company pursuant to a Registration Statement on Form S-3 (File No. 333-290308),
which was filed with the Securities and Exchange Commission on September 16, 2025 and became effective by operation of law on November
3, 2025 (the &#8220;Registration Statement&#8221;), the base prospectus filed as part of the Registration Statement, and the prospectus
supplement dated <span>February 19, 2026.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement contains customary representations and warranties, agreements of the Company and the Investors and customary indemnification
rights and obligations of the parties. Pursuant to the terms of the Purchase Agreement, the Company has agreed to certain restrictions
on the issuance and sale of its Common Stock or Common Stock Equivalents (as defined in the Purchase Agreement) during the 75-day period
following the closing of the Offering. Additionally, pursuant to the lock-up agreement (the &#8220;Lock-Up Agreement&#8221;) each of
the directors, executive officers and 5% holders of the Company, agreed not to sell or transfer any of the Company&#8217;s securities
which they hold, subject to certain exceptions as set forth in the Lock-Up Agreement, during the 75-day period following the date of
the Closing (as defined in the Purchase Agreement).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
holder of Pre-Funded Warrants (together with its affiliates) may not exercise any portion of a Pre-Funded Warrant to the extent that,
after giving effect to such exercise, the holder (together with the holder&#8217;s affiliates, and any other persons acting as a group
together with the holder or any of the holder&#8217;s affiliates) would beneficially own in excess of 4.99% (or, at the holder&#8217;s
option upon issuance, 9.99%) of the number of shares of our common stock outstanding immediately after giving effect to the issuance
of shares of common stock issuable upon exercise of such warrant. The beneficial ownership limitation may be increased at the option
of the holder upon 61 days&#8217; prior notice to the Company, provided, however, that, the beneficial ownership limitation may not exceed
19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock
upon exercise of such Pre-Funded Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Offering, the Company entered into a placement agency agreement (the &#8220;Placement Agency Agreement&#8221;)
with Titan Partners Group LLC, a division of American Capital Partners, LLC (&#8220;Titan Partners&#8221;), pursuant to which the
Company engaged Titan Partners as the placement agent (the &#8220;Placement Agent&#8221;) in connection with the Offering. The
Company agreed to pay the Placement Agent a fee in cash equal to approximately 7.0% of the gross proceeds, a non-accountable expense allowance in the amount of 0.5% of the gross
proceeds, as well as to issue
to the Placement Agent placement agent warrants to purchase up to 118,694 shares of Common Stock, with an exercise price equal to
110% of the public offering price of the shares (the &#8220;Placement Agent Warrants&#8221;). The Company also agreed to
reimburse the Placement Agent for all reasonable and documented out-of-pocket expenses, including the reasonable fees of legal
counsel not to exceed $100,000. The Placement Agency Agreement also contains representations, warranties, indemnification and other
provisions customary for transactions of this nature.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of the Placement Agent Warrants and the shares of Common Stock underlying the Placement Agent Warrants was not registered under
the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) or any state securities laws and were issued in reliance on
the exemption from registration provided by Section 4(a)(2) under the Securities Act and/or Regulation D promulgated thereunder for transactions
not involving a public offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing summaries of the Placement Agent Warrant, the Pre-Funded Warrant, the Placement Agency Agreement and the Purchase Agreement
do not purport to be complete and are subject to, and qualified in their entirety by, such documents attached as Exhibits 4.1, 4.2, 10.1
and 10.2, respectively, to this Current Report on Form 8-K (the &#8220;Form 8-K&#8221;), which are incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Form 8-K does not constitute an offer to sell any securities or a solicitation of an offer to buy any securities, nor shall there be
any sale of any securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such state or jurisdiction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the opinion of Sullivan &amp; Worcester LLP. relating to the legality of the issuance and sale of the Shares and Pre-Funded Warrants
is attached as Exhibit 5.1 hereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.02. Unregistered Sales of Equity Securities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information under Item 1.01 of this Form 8-K related to the Placement Agent Warrants and the Placement Agent Warrant Shares is incorporated
herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
8.01. Other Events</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 19, 2026, the Company issued a press release (the &#8220;Pricing Press Release&#8221;) announcing the pricing of the Offering.
A copy of the Pricing Press Release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On February 23, 2026, the Company
issued a press release (the &#8220;Closing Press Release&#8221;) announcing the closing of the Offering. A copy of the Press Release
is attached hereto as Exhibit 99.2 and is incorporated by reference herein.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01. Financial Statements and Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-1.htm">Form of Placement Agent Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-2.htm">Form of Pre-Funded Warrant</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex5-1.htm">Opinion of Sullivan &amp; Worcester LLP.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><a href="ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement Agency Agreement, dated February 19, 2026, by and between the Company and Titan Partners Group LLC.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-2.htm">Form of Securities Purchase Agreement, dated as of February 19, 2026, by and between the Company and the purchaser thereto.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex5-1.htm">Consent of Sullivan &amp; Worcester LLP. (included in Exhibit 5.1).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Pricing Press Release, dated February 19, 2026.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><a href="ex99-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing Press Release, dated February 23, 2026.</span></a></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>*
</b>Schedules or exhibits omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish supplementally a copy of
any omitted schedule or exhibit to the Securities and Exchange Commission upon request.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ABUNDIA
    GLOBAL IMPACT GROUP, INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    February 23, 2026</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Edward Gillespie</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Edward
    Gillespie</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6PeZWRXB3OuYQp8gQ8ba4KMWtGWn9eyTf0rohhgMhOedLhAhFQUvdIMNxUZWwx7ZrlEOo8IyM5oQ+ka3WKfhe4UVbx8q4fvyBGXkGPTONxsrv++RdW6xTiOVIek0hkelkBvONCL5+RuasazROqwaUqWHH1LFGp/g1XNirJxlqX/2nA7LVZFJIoniw3yDjRMKW7upBfLVQlpkIwr4CUTDdOp/Knw7Nl4S8wda/swP9V/ABxR1KUQ== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ex4-1.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES. THE REGISTERED
HOLDER OF THIS SECURITY BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS SECURITY OR THE SECURITIES FOR
WHICH THIS SECURITY IS EXERCISABLE EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT COVERING THIS SECURITY OR PURSUANT TO AN EXEMPTION
FROM REGISTRATION UNDER THE SECURITIES ACT AND OTHERWISE AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS SECURITY AGREES THAT IT
WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS SECURITY FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE DATE OF THE
PURCHASE AGREEMENT (DEFINED BELOW) TO ANYONE OTHER THAN (I) THE PLACEMENT AGENT OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING,
OR (II) A BONA FIDE OFFICER, PARTNER OR AFFILIATE OF AMERICAN CAPITAL PARTNERS, LLC OR OF ANY SUCH PLACEMENT AGENT OR SELECTED DEALER.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
WARRANT IS NOT EXERCISABLE PRIOR TO [&nbsp;&nbsp;], 2026. VOID AFTER 5:00 P.M., EASTERN TIME, [&nbsp;&nbsp;], 2031.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLACEMENT
AGENT&rsquo;S PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Abundia
Global Impact Group, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrant
    Shares: _________</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: right">Initial Exercise Date: _____, 2026</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issue
    Date: _______, 2026</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
<B>PLACEMENT AGENT&rsquo;S PURCHASE WARRANT</B> (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, American Capital
Partners, LLC or its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise
and the conditions hereinafter set forth, at any time on or after the date referred to above as the Initial Exercise Date (the &ldquo;<U>Initial
Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on [&nbsp;&nbsp;], 2031 (the &ldquo;<U>Termination Date</U>&rdquo;)
but not thereafter, to subscribe for and purchase from <FONT STYLE="text-transform: uppercase">Abundia Global Impact Group, Inc.</FONT>,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to [&nbsp;&nbsp;] shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant
Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise
Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities
Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated February [&nbsp;&nbsp;], 2026, between the Company and the purchasers party
thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy
or PDF copy submitted by email (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within one (1) Trading Day, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable
Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless exercise procedure specified
in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything
herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased
all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this
Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered
to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available
hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the
applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares
purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading Day
of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the
provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available
for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $[&nbsp;&nbsp;], subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Cashless
Exercise</U>. In lieu of exercising this Warrant by delivering the aggregate Exercise Price by wire transfer or cashier&rsquo;s check,
at the election of Holder, this Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo;
in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by
(A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD>
    <TD STYLE="width: 0.1in">= </TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal
securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding
the date of the applicable Notice of Exercise or (z) the bid price of the Common Stock on the principal Trading Market as reported by
Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if
such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours
thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section
2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day
and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading
hours&rdquo; on such Trading Day;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="width: 0.1in">= </TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Exercise Price of this Warrant, as adjusted hereunder;
and</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in">&nbsp;</TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)</FONT></TD>
    <TD STYLE="width: 0.1in">= </TD>
  <TD STYLE="text-align: justify; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of Warrant Shares that would be issuable upon
exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a
cashless exercise.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 139.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock are then listed
or quoted on The New York Stock Exchange, the NYSE American or any tier of The Nasdaq Stock Market (each, a &ldquo;<U>Trading Market</U>&rdquo;),
the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which
the Common Stock are then listed or quoted as reported by Bloomberg (based on a trading day from 9:30 a.m. (New York City time) to 4:02
p.m. (New York City time)), (b) if the Common Stock are listed or quoted on the OTCQB or OTCQX (each as operated by OTC Markets Group,
Inc., or any successor market), the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on
OTCQB or OTCQX as applicable, (c) if the Common Stock are not then listed or quoted for trading on the OTCQB or OTCQX Markets and if
prices for the Common Stock are then reported in the OTC Pink Market published by OTC Markets Group Inc. (or a similar organization or
agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)
in all other cases, the fair market value of a Common Stock as determined by an independent appraiser selected in good faith by the Board
of Directors of the Company and reasonably acceptable to the Holder, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised, and the holding period
of the Warrants being exercised may be tacked onto the holding period of the Warrant Shares. The Company agrees not to take any position
contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Mechanics
of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the transfer agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company by the Holder of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery on the Notice of Exercise.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii. <U>Rescission
Rights</U>. If the Company fails to cause the transfer agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise; <U>provided, however</U>, that the
Holder shall be required to return any Warrant Shares or Common Stock subject to any such rescinded exercise notice concurrently with
the return to the Holder of the aggregate Exercise Price paid to the Company for such Warrant Shares and the restoration of the Holder&rsquo;s
right to acquire such Warrant Shares pursuant to this Warrant (including, issuance of a replacement warrant certificate evidencing such
restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the transfer agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all transfer agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;Attribution Parties&rdquo;)), would
beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares
of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the
number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially
owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted
portion of any other securities of the Company (including, without limitation, any securities of the Company or its Subsidiaries which
would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right,
option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the
holder thereof to receive, Common Stock (the &ldquo;<U>Common Stock Equivalents</U>&rdquo;)) subject to a limitation on conversion or
exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.
Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance
with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that
the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder
is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in
this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder
together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion
of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant
is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which
portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation
to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall
be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the
case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the transfer
agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall
within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case,
the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number
of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon
election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of Common Stock outstanding immediately after
giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company,
may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership
Limitation in no event exceeds 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance
of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to
apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered
to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with
the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to
such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification. For the purposes of clarification, the Exercise Price
of this Warrant will not be adjusted in the event that the Company or any subsidiary thereof, as applicable, sells or grants any option
to purchase, or sell or any grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option
to purchase or other disposition) any Common Stock or Common Stock Equivalents, at an effective price per share less than the Exercise
Price then in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder&rsquo;s right
to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall
not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result
of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time,
if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Pro
Rata Distribution</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution (other than cash) of stock or other securities, property or options by way of a dividend, spin off,
reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent
(or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised
at the time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the
Holder has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of the Company&rsquo;s
assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether
by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their
shares for other securities, cash or property and has been accepted by the holders of more than 50% of the outstanding shares of Common
Stock of the Company or more than 50% of the voting power of the outstanding common and preferred stocks of the Company, (iv) the Company,
directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of shares
of Common Stock or any compulsory share exchange pursuant to which the shares of Common Stock are effectively converted into or exchanged
for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a
stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of
the outstanding shares of Common Stock of the Company or more than 50% of the aggregate voting power of the outstanding common and preferred
stocks of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the
Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to
the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the
exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is
the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result
of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and
the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. As used herein, &ldquo;<U>Person</U>&rdquo; means
an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Notice
to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (and all of its Subsidiaries, taken as a whole) is a party, any
sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock
is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation
or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the
Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar
days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be
taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as
of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are
to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected
to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to
exchange their shares of Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger,
sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall
not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this
Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall
simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise
this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except
as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Transferability</U>.
Pursuant to FINRA Rule 5110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred,
assigned, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put or call transaction that would result
in the effective economic disposition of the securities by any person for a period of 180 days immediately following the commencement
of sales of the offering pursuant to which this Warrant is being issued, except as permitted under FINRA Rule 5110(e)(2). Subject to
the foregoing restriction, this Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant
at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the
form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon
the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant
or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant
to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this
Warrant in full. This Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant
Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and
shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by or on behalf of the Company for that purpose
(the &ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat
the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the
Holder, and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Representation
by Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Registration Rights</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) To
the extent the Company does not maintain an effective registration statement for the Warrant Shares and in the further event that the
Company files a registration statement with the Securities and Exchange Commission covering the sale of its shares of Common Stock (other
than a registration statement on Form S-4 or S-8, or on another form, or in another context, in which such &ldquo;piggyback&rdquo; registration
would be inappropriate), then, for a period of five (5) years from the commencement of sales of the Offering, the Company shall give
written notice of such proposed filing to the Holder as soon as practicable but in no event less than ten (10) days before the anticipated
filing date, which notice shall describe the amount and type of securities to be included in such offering, the intended method(s) of
distribution, and the name of the proposed managing underwriter or underwriters, if any, of the offering, and offer to the Holder in
such notice the opportunity to register the sale of such number of shares of Warrant Shares as such Holder may request in writing within
five (5) days following receipt of such notice (a &ldquo;<U>Piggyback Registration</U>&rdquo;). The Company shall use its commercially
reasonable efforts to cause the managing underwriter or underwriters of a proposed underwritten offering to permit the Warrant Shares
requested to be included in a Piggyback Registration on the same terms and conditions as any similar securities of the Company and to
permit the sale or other disposition of such Warrant Shares in accordance with the intended method(s) of distribution thereof. All Holders
proposing to distribute their securities through a Piggyback Registration that involves an underwriter or underwriters shall enter into
an underwriting agreement in customary form with the underwriter or underwriters selected for such Piggyback Registration. Furthermore,
each Holder must provide such information as reasonably requested by the Company (which information shall be limited to that which is
required for disclosure under the Securities Act and the forms, rules and regulations promulgated thereunder) to be included in the registration
statement timely or the Company may elect to exclude such Holder from the registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) In
addition, to the extent the Company does not maintain an effective registration statement for the Warrant Shares, for a period of five
(5) years from the commencement of sales of the Offering, the Holder shall be entitled to one (1) demand right for the registration of
the Warrant Shares at the Company&rsquo;s expense (other than any underwriting discounts, selling commissions, share transfer taxes applicable
to the sale of the Warrant Shares, and fees and disbursements of counsel for the Holder) (the &ldquo;<U>Demand Registration</U>&rdquo;).
In the event of a Demand Registration, the Company shall use its commercially reasonable efforts to register the applicable Warrant Shares
within sixty (60) days after receiving the Demand Registration. All Holders of Warrant Shares proposing to distribute their securities
through a Demand Registration that involves an underwriter or underwriters shall enter into an underwriting agreement in customary form
with the underwriter or underwriters selected for such Demand Registration. Furthermore, each Holder must provide such information as
reasonably requested by the Company (which information shall be limited to that which is required for disclosure under the Securities
Act and the forms, rules and regulations promulgated thereunder) to be included in the registration statement timely or the Company may
elect to exclude such Holder from the registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) Notwithstanding
the foregoing, the registration rights described in this Section 5 shall be subject to limitations imposed by the Commission&rsquo;s
rules or comments of the Commission staff in connection with its review of the registration statement for any such resale registration.
Moreover, notwithstanding the foregoing registration obligations of the Company, if the Company furnishes to the Holders requesting a
Demand Registration a certificate signed by the Company&rsquo;s chief executive officer stating that in the good faith judgment of the
Company&rsquo;s Board of Directors it would be materially detrimental to the Company and its stockholders for a registration statement
to either become effective or remain effective for as long as such registration statement otherwise would be required to remain effective,
because such action would (i) materially interfere with a significant acquisition, corporate reorganization, or other similar transaction
involving the Company; (ii) require premature disclosure of material information that the Company has a bona fide business purpose for
preserving as confidential; or (iii) render the Company unable to comply with requirements under the Securities Act or Exchange Act,
then the Company shall have the right to defer taking action with respect to such Demand Registration or withdraw a related registration
statement for a period of not more than forty-five (45) calendar days; provided, however, that the Company may not invoke this right
more than twice in any twelve (12) month period or during the twelve (12) month period prior to the Termination Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
6</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(iv) herein, in no event shall the Company be required to net cash settle
an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Authorized
Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii. Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Governing
Law; Venue</U>. This Warrant shall be deemed to have been executed and delivered in New York and both this Warrant and the transactions
contemplated hereby shall be governed as to validity, interpretation, construction, effect, and in all other respects by the laws of
the State of New York applicable to agreements wholly performed within the borders of such state and without regard to the conflicts
of laws principals thereof (other than Section 5-1401 of The New York General Obligations Law). Each of the Holder and the Company: (a)
agrees that any legal suit, action or proceeding arising out of or relating to this Warrant and/or the transactions contemplated hereby
shall be instituted exclusively in the Supreme Court of the State of New York, New York County, or in the United States District Court
for the Southern District of New York, (b) waives any objection which it may have or hereafter to the venue of any such suit, action
or proceeding, and (c) irrevocably consents to the jurisdiction of Supreme Court of the State of New York, New York County, or in the
United States District Court for the Southern District of New York in any such suit, action or proceeding. Each of the Holder and the
Company further agrees to accept and acknowledge service of any and all process which may be served in any such suit, action or proceeding
in the Supreme Court of the State of New York, New York County, or in the United States District Court for the Southern District of New
York and agrees that service of process upon the Company mailed by certified mail to the Company&rsquo;s address or delivered by Federal
Express via overnight delivery shall be deemed in every respect effective service of process upon the Company, in any such suit, action
or proceeding, and service of process upon the Holder mailed by certified mail to the Holder&rsquo;s address or delivered by Federal
Express via overnight delivery shall be deemed in every respect effective service process upon the Holder, in any such suit, action or
proceeding. THE HOLDER (ON BEHALF OF ITSELF, ITS SUBSIDIARIES AND, TO THE FULLEST EXTENT PERMITTED BY LAW, ON BEHALF OF ITS RESPECTIVE
EQUITY HOLDERS AND CREDITORS) HEREBY WAIVES ANY RIGHT HOLDER MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY CLAIM BASED UPON, ARISING
OUT OF OR IN CONNECTION WITH THIS WARRANT AND THE TRANSACTIONS CONTEMPLATED BY THIS WARRANT.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of
this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material
damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including,
but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting
any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Notices</U>.
Any and all notices or other communications or deliveries to be provided hereunder shall be made in accordance with Section 5.4 of the
Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder of this Warrant, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABUNDIA
    GLOBAL IMPACT GROUP, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To: <B>ABUNDIA
GLOBAL IMPACT GROUP, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) Payment
shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ___________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: justify"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: ___________________<U> </U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address: ____________________<U> </U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ex4-2.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
4.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRE-FUNDED
COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Abundia
Global Impact Group, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrant Shares: _________</B></FONT></TD>
  <TD STYLE="text-align: right; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Initial Exercise Date: _____, 2026</B></FONT></TD>
  </TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
<B>PRE-FUNDED COMMON STOCK PURCHASE WARRANT</B> (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________
or its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) until this Warrant is
exercised in full (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Abundia Global Impact
Group, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to ______ shares (as subject to adjustment hereunder, the
&ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal
to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Securities Purchase Agreement</U>&rdquo;), dated _____, 2026, between the Company and the
purchasers signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless
the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records
showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice
of Exercise within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge
and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the
number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.001 per Warrant Share,
was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the
nominal exercise price of $0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of
this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price
under any circumstance or for any reason whatsoever. The remaining unpaid exercise price per share of Common Stock under this Warrant
shall be $0.001, subject to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo;
in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by
(A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(A) =</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">as applicable: (i) the VWAP on the Trading
  Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered
  pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof
  on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated
  under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately
  preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as
  reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice
  of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within
  two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant
  to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is
  a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular
  trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B) =</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the Exercise Price of this Warrant, as adjusted
  hereunder; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X) =</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the number of Warrant Shares that would be
  issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise
  rather than a cashless exercise.</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (&ldquo;<U>Pink
Market</U>&rdquo;) (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per
share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an
independent appraiser selected in good faith by the purchasers of a majority in interest of the Securities then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or the OTCQX Best
Market (&ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or
the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB
or OTCQX and if prices for the Common Stock are then reported on the Pink Market operated by the OTC Markets, Inc. (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)
in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith
by the purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and
expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mechanics
                                            of Exercise</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the transfer agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system if the Company is then a participant in such system and either (A)
there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by Holder
or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered in the
Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled
pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two
(2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate
Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the
Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise,
the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which
this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise
Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number
of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any
reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall
pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based
on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading
Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until
such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant
in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect to any
Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York City time) on the Initial Exercise Date, which may be delivered at
any time after the time of execution of the Securities Purchase Agreement, the Company agrees to deliver the Warrant Shares subject to
such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share
Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise)
is received by such Warrant Share Delivery Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the transfer agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the transfer agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all transfer agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Holder&rsquo;s
                                            Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and
                                            a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section
                                            2 or otherwise, to the extent that after giving effect to such issuance after exercise as
                                            set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s
                                            Affiliates, and any other Persons acting as a group together with the Holder or any of the
                                            Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would
                                            beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For
                                            purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned
                                            by the Holder and its Affiliates and Attribution Parties shall include the number of shares
                                            of Common Stock issuable upon exercise of this Warrant with respect to which such determination
                                            is being made, but shall exclude the number of shares of Common Stock which would be issuable
                                            upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned
                                            by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion
                                            of the unexercised or nonconverted portion of any other securities of the Company (including,
                                            without limitation, any other securities of the Company or its Subsidiaries which would entitle
                                            the holder thereof to acquire at any time Common Stock, including, without limitation, any
                                            debt, preferred stock, right, option, warrant or other instrument that is at any time convertible
                                            into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive,
                                            Common Stock (the &ldquo;Common Stock Equivalents&rdquo;)) subject to a limitation on conversion
                                            or exercise analogous to the limitation contained herein beneficially owned by the Holder
                                            or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence,
                                            for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance
                                            with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
                                            it being acknowledged by the Holder that the Company is not representing to the Holder that
                                            such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is
                                            solely responsible for any schedules required to be filed in accordance therewith. To the
                                            extent that the limitation contained in this Section 2(e) applies, the determination of whether
                                            this Warrant is exercisable (in relation to other securities owned by the Holder together
                                            with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
                                            shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise
                                            shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable
                                            (in relation to other securities owned by the Holder together with any Affiliates and Attribution
                                            Parties) and of which portion of this Warrant is exercisable, in each case subject to the
                                            Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm
                                            the accuracy of such determination. In addition, a determination as to any group status as
                                            contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act
                                            and the rules and regulations promulgated thereunder. For purposes of this Section 2(e),
                                            in determining the number of outstanding shares of Common Stock, a Holder may rely on the
                                            number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most
                                            recent periodic or annual report filed with the Commission, as the case may be, (B) a more
                                            recent public announcement by the Company or (C) a more recent written notice by the Company
                                            or the transfer agent setting forth the number of shares of Common Stock outstanding. Upon
                                            the written or oral request of a Holder, the Company shall within one Trading Day confirm
                                            orally and in writing to the Holder the number of shares of Common Stock then outstanding.
                                            In any case, the number of outstanding shares of Common Stock shall be determined after giving
                                            effect to the conversion or exercise of securities of the Company, including this Warrant,
                                            by the Holder or its Affiliates or Attribution Parties since the date as of which such number
                                            of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
                                            shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%)
                                            of the number of shares of the Common Stock outstanding immediately after giving effect to
                                            the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder,
                                            upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation
                                            provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no
                                            event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after
                                            giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held
                                            by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase
                                            in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day
                                            after such notice is delivered to the Company. The provisions of this paragraph shall be
                                            construed and implemented in a manner otherwise than in strict conformity with the terms
                                            of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective
                                            or inconsistent with the intended Beneficial Ownership Limitation herein contained or to
                                            make changes or supplements necessary or desirable to properly give effect to such limitation.
                                            The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that, to
the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership
of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held
in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent
(or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised
at the time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the
Holder has exercised this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or any Subsidiary,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding
Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one
or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share
exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v)
the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another
Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares of Common Stock or 50% or
more of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent
exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such
exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation
in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of
the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this
Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the
securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor
entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in
writing all of the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(e) pursuant to written
agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior
to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the
term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead
to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor
Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity
or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents
with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the
Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(e) regardless
of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a
Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. This Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Securities Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this
Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient
to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Abundia Global
  Impact Group, Inc.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="vertical-align: top; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>To:</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>ABUNDIA
                                            GLOBAL IMPACT GROUP, INC.</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;
] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
&nbsp;&nbsp;] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth
in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless
exercise procedure set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ___________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ASSIGNMENT
FORM</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Email Address:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: _______________ __, ______</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature: ________________________________</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address: _________________________________</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ex5-1.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex5-1_001.jpg" ALT="" style="width:720px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.75in; text-align: right; text-indent: 0.5in">February 23, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Abundia Global Impact Group, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">1300 Post Oak Blvd., Suite 1305</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Houston, Texas 77056</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 290.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">We have acted as counsel to Abundia Global Impact
Group, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), in connection with the offering of an aggregate of 4,134,175 shares of
common stock, par value $0.001 per share, of the Company at a price of $3.37 per share (collectively, the &ldquo;Shares&rdquo;) and (ii)
pre-funded warrants to purchase up to 1,800,543 shares of Common Stock (the &ldquo;Pre-Funded Warrants&rdquo;, and the shares of Common
Stock issuable upon the exercise of the Pre-Funded Warrants, the &ldquo;Pre-Funded Warrant Shares&rdquo;). The Shares and Pre-funded Warrants
are being sold pursuant to a prospectus supplement, dated February 19, 2026, and the accompanying base prospectus (together, the &ldquo;Prospectus&rdquo;)
that form a part of the Company&rsquo;s Registration Statement on Form S-3 (File No. 333-290308) (the &ldquo;Registration Statement&rdquo;),
originally filed by the Company with the U.S. Securities and Exchange Commission (the &ldquo;Commission&rdquo;) under the Securities Act
of 1933, as amended (the &ldquo;Securities Act&rdquo;), on September 16, 2025, and became effective by operation of law on November 3,
2025, in accordance with the Securities Purchase Agreement (the &ldquo;Securities Purchase Agreement&rdquo;) dated as of February 19,
2026, by and among the Company and certain investors party thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">This opinion is being furnished in accordance with
the requirements of Item 601(b)(5) of Regulation S-K under the Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">As counsel to the Company in connection with the issuance
and sale of the Shares and the Pre-Funded Warrants we have examined: (i) the Company&rsquo;s certificate of incorporation, as amended,
and the Company&rsquo;s amended and restated bylaws, both as currently in effect; (ii) certain resolutions of the board of directors and
a pricing committee thereof relating to the issuance and sale of the Shares and the Pre-Funded Warrants; (iii) the Securities Purchase
Agreement; (iv) the form of Pre-Funded Warrant; (v) the Prospectus and the Registration Statement; and (v) such other proceedings, documents,
and records as we have deemed necessary to enable us to render this opinion. In all such examinations, we have assumed the genuineness
of all signatures, the authenticity of all documents, certificates, and instruments submitted to us as originals, and the conformity with
the originals of all documents, certificates, and instruments submitted to us as copies. We have also assumed the due execution and delivery
of all documents where due execution and delivery are prerequisite to the effectiveness thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Our opinions expressed herein are subject to the following
qualifications and exceptions: (i) the effect of bankruptcy, insolvency, reorganization, arrangement, moratorium, or other similar laws
relating to or affecting the rights of creditors generally, including, without limitation, laws relating to fraudulent transfers or conveyances,
preferences, and equitable subordination; (ii) the effect of general principles of equity, including, without limitation, concepts of
materiality, reasonableness, good faith and fair dealing (regardless of whether considered in a proceeding in equity or at law); and (iii)
we render no opinion as to the effect of the laws of any state or jurisdiction other than the General Corporation Law of the State of
Delaware and the laws of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Based upon and subject to the foregoing, it is
our opinion that the Shares and Pre-Funded Warrants have been duly authorized for issuance, and when issued and delivered in
accordance with the Securities Purchase Agreement and Prospectus against payment of consideration as contemplated therein, the
Shares and the Pre-Funded Warrants will be validly issued, fully paid and non-assessable. If, when and to the extent any Pre-Funded
Warrant Shares are issued in accordance with the terms of, and in the manner contemplated by, the Securities Purchase Agreement,
including the due and proper exercise of the relevant Pre-Funded Warrants in accordance therewith and payment in full to the Company
of any and all consideration for such Pre-Funded Warrant Shares as required thereunder, such Pre-Funded Warrant Shares will be
validly issued, fully paid and nonassessable</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">This opinion is given as of the date hereof and we
assume no obligation to advise you of changes that may thereafter be brought to our attention.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">We hereby consent to the reference to our firm under
the caption &ldquo;Legal Matters&rdquo; in the Prospectus, which forms a part of the Registration Statement and to the filing of this
opinion with the Commission as an exhibit to a Current Report on Form 8-K filed by the Company with the Commission. In giving this consent,
we do not thereby admit that we are experts within the meaning of Section 11 of the Securities Act or included in the category of persons
whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Sullivan &amp; Worcester LLP</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><IMG SRC="ex5-1_002.jpg" ALT="" style="width:350px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>ex10-1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLACEMENT
AGENCY AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
19, 2026</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Titan
Partners Group LLC,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
division of American Capital Partners, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4
World Trade Center, 49th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10007</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Introductory</B>.
This Placement Agency Agreement the (&ldquo;<B>Agreement</B>&rdquo;) sets forth the terms upon which Titan Partners Group LLC, a division
of American Capital Partners, LLC ( &ldquo;<B>Placement Agent</B>&rdquo;), shall be engaged by Abundia Global Impact Group, Inc., a Delaware
corporation (the &ldquo;<B>Company</B>&rdquo;), to act as the exclusive Placement Agent in connection with the registered direct offering
(hereinafter referred to as the &ldquo;<B>Placement</B>&rdquo;) of (i) shares of common stock, par value $0.001 per share (the &ldquo;<B>Common
Stock</B>&rdquo; and the Common Stock offered in the Placement, the &ldquo;<B>Placement Shares</B>&rdquo;), of the Company and (ii) pre-funded
warrants (the &ldquo;<B>Pre-funded Warrants</B>&rdquo;) to purchase shares of Common Stock at an exercise price equal to $0.001 per share.
The Placement Shares and the Pre-Funded Warrants are collectively referred to as the &ldquo;<B>Placement Securities</B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of the Placement and the Placement Securities shall be mutually agreed upon by the Company and the purchasers (each, a &ldquo;<B>Purchaser</B>&rdquo;
and collectively, the &ldquo;<B>Purchasers</B>&rdquo;) and nothing herein constitutes that the Placement Agent would have the power or
authority to bind the Company or any Purchaser or an obligation for the Company to issue any Placement Securities or complete the Placement.
The date of the closing of the Placement shall be referred to herein as the &ldquo;<B>Closing Date</B>&rdquo;. The Company expressly
acknowledges and agrees that the Placement Agent&rsquo;s obligations hereunder are on a reasonable best efforts basis only and that the
execution of this Agreement does not constitute a commitment by the Placement Agent to purchase the Placement Securities and does not
ensure the successful placement of the Placement Securities or any portion thereof or the success of the Placement Agent with respect
to securing any other financing on behalf of the Company. Following the prior written consent of the Company, the Placement Agent may
retain other brokers or dealers to act as sub-agents or selected-dealers on its behalf in connection with the Placement. The sale of
the Placement Securities to any Purchaser will be evidenced by the securities purchase agreement (the &ldquo;<B>Purchase Agreement</B>&rdquo;)
by and among the Company and such Purchasers in the form of <U>Exhibit A</U> attached hereto. Capitalized terms that are not otherwise
defined herein have the meanings given to such terms in the Purchase Agreement. Prior to the signing of any Purchase Agreement, executive
officers of the Company will be available upon reasonable notice and during normal business hours to answer inquiries from prospective
Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
1</U>. <U>REPRESENTATIONS AND WARRANTIES OF THE COMPANY; COVENANTS OF THE COMPANY</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
<U>Representations of the Company</U>. With respect to the Placement Securities, each of the representations and warranties (together
with any related disclosure schedules thereto) and covenants made by the Company to the Purchasers in the Purchase Agreement in connection
with the Placement, is hereby incorporated herein by reference into this Agreement (as though fully restated herein) and is, as of the
date of this Agreement and as of each Closing Date, hereby made to, and in favor of, the Placement Agent. In addition to the foregoing,
the Company represents and warrants that there are no affiliations with any FINRA member firm participating in the Placement among the
Company&rsquo;s officers, directors or, to the knowledge of the Company, any five percent (5.0%) or greater stockholder of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
<U>Covenants of the Company</U>. The Company covenants and agrees to continue to retain (i) a firm of independent PCAOB registered public
accountants for a period of at least three (3) years after the Closing Date and (ii) a competent transfer agent with respect to the Common
Stock for a period of three (3) years after the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
2</U>. <U>REPRESENTATIONS OF THE PLACEMENT AGENT</U>. The Placement Agent represents and warrants that it (i) is a member in good standing
of the Financial Industry Regulatory Authority (&ldquo;<B>FINRA</B>&rdquo;), (ii) is registered as a broker/dealer under the Securities
Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;), (iii) is licensed as a broker/dealer under the laws of the
United States of America, applicable to the offers and sales of the Placement Securities by the Placement Agent, (iv) is and will be
a corporate body validly existing under the laws of its place of incorporation, and (v) has full power and authority to enter into and
perform its obligations under this Agreement. The Placement Agent will immediately notify the Company in writing of any change in its
status with respect to subsections (i) through (v) above. The Placement Agent covenants that it will use its reasonable best efforts
to conduct the Placement hereunder in compliance with the provisions of this Agreement and the requirements of applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
3</U>. <U>COMPENSATION</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
<U>Cash Compensation</U>. In consideration of the services to be provided for hereunder, the Company shall pay to the Placement Agent
or its respective designees a total cash fee equal to seven percent (7.0%) of the gross proceeds from the Placement of the total amount
of Placement Securities sold.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
Non-Accountable Expense Allowance. On the Closing Date, the Company shall pay to the Placement Agent a non-accountable expense allowance
in the amount of one-half percent (0.5%) of the gross proceeds from the Placement of the total amount of Placement Securities sold.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
<U>Warrant Compensation</U>. In consideration of the services to be provided for hereunder, the Company shall pay to the Placement Agent
or its respective designees at the Closing Date warrants (&ldquo;<B>Agent Warrants</B>&rdquo;) for the purchase of an aggregate of a
number of shares of Common Stock (the &ldquo;<B>Agent Warrant Shares</B>&rdquo;), representing two percent (2.0%) of the Placement Securities
sold at such Closing Date. The Agent Warrants, in the form of <U>Exhibit C </U>hereto, shall be exercisable, in whole or in part, commencing
on the date that is 180 days after the date of this Agreement and expiring on the five-year anniversary of the date of this Agreement
at an initial exercise price per share of Common Stock of $3.707. The Placement Agent understands and agrees that there are significant
restrictions pursuant to FINRA Rule 5110 against transferring the Agent Warrants and the Agent Warrant Shares during the one hundred
eighty (180) days after this Agreement and by its acceptance thereof shall agree that it will not sell, transfer, assign, pledge or hypothecate
the Agent Warrants, or any portion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would
result in the effective economic disposition of such securities for a period of one hundred eighty (180) days following the date of this
Agreement to anyone other than (i) a sub-agent or selected-dealer in connection with the Placement or (ii) a bona fide officer, partner,
employee or registered representative of the Placement Agent, sub-agent or selected-dealer; and only if any such transferee agrees to
the foregoing lock-up restrictions. Delivery of the Agent Warrants shall be made at the relevant Closing Date, and shall be issued in
the name or names and in such authorized denominations as the Placement Agent may request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
<U>Reduction of Compensation</U>. The Placement Agent reserves the right to reduce any item of compensation or adjust the terms thereof
as specified herein in the event that a determination shall be made by FINRA to the effect that the Placement Agent&rsquo;s aggregate
compensation is in excess of FINRA Rules or that the terms thereof require adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
4. EXPENSES</U>. The Company agrees to pay all costs, fees and expenses incurred in connection with the performance of its obligations
hereunder and in connection with the transactions contemplated hereby, including, without limitation: (i) all expenses incident to the
issuance, delivery and qualification of the Placement Securities (including all printing and engraving costs); (ii) all fees and expenses
of the registrar and transfer agent for the Common Stock; (iii) all necessary issue, transfer and other stamp taxes in connection with
the issuance and sale of the Placement Securities; (iv) all fees and expenses of the Company&rsquo;s counsel, independent public or certified
public accountants and other advisors; (v) all costs and expenses incurred in connection with the preparation, printing, filing, shipping
and distribution of the Registration Statement (including financial statements, exhibits, schedules, consents and certificates of experts),
and the Prospectus, and all amendments and supplements thereto, and this Agreement; (vi) all filing fees, reasonable attorneys&rsquo;
fees and expenses incurred by the Company in connection with qualifying or registering (or obtaining exemptions from the qualification
or registration of) all or any part of the Placement Securities for offer and sale under the state securities or blue sky laws or the
securities laws of any other country; (vii) the fees and expenses associated with including the Placement Common Stock on the Trading
Market; (viii) up to $100,000 for the fees and expenses of the Placement Agent, including the fees and expenses of Mintz, Levin, Cohn,
Ferris, Glovsky and Popeo, P.C., counsel to the Placement Agent. The Placement Agent may deduct from the net proceeds of the offering
payable to the Company on each Closing Date, the expenses set forth herein to be paid by the Company to the Placement Agent, to the extent
not already paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
5</U>. <U>INDEMNIFICATION</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
To the extent permitted by law, with respect to the Placement Securities, the Company will indemnify the Placement Agent and its affiliates,
stockholders, directors, officers, employees, members and controlling persons (within the meaning of Section 15 of the Securities Act
or Section 20 of the Exchange Act) against all losses, claims, damages, expenses and liabilities, as the same are incurred (including
the reasonable fees and expenses of counsel), relating to or arising out of its activities hereunder or pursuant to this Agreement or
the Purchase Agreement, including, without limitation, any failure by the Company to obtain any required consent, except to the extent
that any losses, claims, damages, expenses or liabilities (or actions in respect thereof) are found in a final judgment (not subject
to appeal) by a court of law to have resulted primarily and directly from a Placement Agent&rsquo;s willful misconduct or gross negligence
in performing the services described herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
Promptly after receipt by the Placement Agent of notice of any claim or the commencement of any action or proceeding with respect to
which the Placement Agent is entitled to indemnity hereunder, the Placement Agent will promptly notify the Company in writing of such
claim or of the commencement of such action or proceeding, but failure to so notify the Company shall not relieve the Company from any
obligation it may have hereunder, except and only to the extent such failure results in the forfeiture by the Company of substantial
rights and defenses. If the Company so elects or is requested by the Placement Agent, the Company will assume the defense of such action
or proceeding and will employ counsel reasonably satisfactory to the Placement Agent and will pay the reasonable and documented fees
and expenses of such counsel. Notwithstanding the preceding sentence, the Placement Agent will be entitled to employ its own counsel
separate from counsel for the Company and from any other party in such action if counsel for the Placement Agent reasonably determines
that it would be inappropriate under the applicable rules of professional responsibility for the same counsel to represent both the Company
and the Placement Agent. In such event, the reasonable fees and disbursements of no more than one such separate counsel will be paid
by the Company, in addition to fees of local counsel. The Company will have the right to settle the claim or proceeding, provided that
the Company will not settle any such claim, action or proceeding without the prior written consent of the Placement Agent, which will
not be unreasonably withheld, conditioned or delayed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
The Company agrees to notify the Placement Agent promptly of the assertion against it or any other person of any claim or the commencement
of any action or proceeding relating to a transaction contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
If for any reason the foregoing indemnity is unavailable to the Placement Agent or insufficient to hold the Placement Agent harmless,
then the Company shall contribute to the amount paid or payable by the Placement Agent as a result of such losses, claims, damages or
liabilities in such proportion as is appropriate to reflect not only the relative benefits received by the Company on the one hand and
the Placement Agent on the other, but also the relative fault of the Company on the one hand and the Placement Agent on the other that
resulted in such losses, claims, damages or liabilities, as well as any relevant equitable considerations. The amounts paid or payable
by a party in respect of losses, claims, damages and liabilities referred to above shall be deemed to include any legal or other fees
and expenses incurred in defending any litigation, proceeding or other action or claim. Notwithstanding the provisions hereof, the Placement
Agent&rsquo;s share of the liability hereunder shall not be in excess of the amount of fees actually received, or to be received, by
the Placement Agent under this Agreement (excluding any amounts received as reimbursement of expenses incurred by the Placement Agent).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.
These indemnification provisions shall remain in full force and effect whether or not the transaction contemplated by this Agreement
is completed and shall survive the termination of this Agreement, and shall be in addition to any liability that the Company might otherwise
have to any indemnified party under this Agreement or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
6</U>. <U>ENGAGEMENT TERM</U>. The Placement Agent&rsquo;s engagement hereunder will be until the later of (i) April 29, 2026 and (ii)
the final Closing Date under the Purchase Agreement. The date of termination of this Agreement is referred to herein as the &ldquo;<B>Termination
Date</B>.&rdquo; In the event, however, in the course of the Placement Agent&rsquo;s performance of due diligence it deems, it necessary
to terminate the engagement, the Placement Agent may do so prior to the Termination Date. The Company may elect to terminate the engagement
hereunder for any reason prior to the Termination Date but will remain responsible for fees pursuant to Section 3 hereof with respect
to the Placement Securities if sold in the Placement. Notwithstanding anything to the contrary contained herein, the provisions concerning
the Company&rsquo;s obligation to pay any fees actually earned pursuant to Section 3 hereof and the provisions concerning confidentiality,
indemnification and contribution contained herein will survive any expiration or termination of this Agreement. If this Agreement is
terminated prior to the completion of the Placement, all fees due to the Placement Agent as set forth in Section 3 shall be paid by the
Company to the Placement Agent on or before the Termination Date (in the event such fees are earned or owed as of the Termination Date).
The Placement Agent agrees not to use any confidential information concerning the Company provided to the Placement Agent by the Company
for any purposes other than those contemplated under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
7</U>. <U>PLACEMENT AGENT INFORMATION</U>. The Company agrees that any information or advice rendered by the Placement Agent in connection
with this engagement is for the confidential use of the Company only in its evaluation of the Placement and, except as otherwise required
by law, the Company will not disclose or otherwise refer to the advice or information in any manner without the Placement Agent&rsquo;s
prior written consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
8</U>. <U>NO FIDUCIARY RELATIONSHIP</U>. This Agreement does not create, and shall not be construed as creating rights enforceable by
any person or entity not a party hereto, except those entitled hereto by virtue of the indemnification provisions hereof. The Company
acknowledges and agrees that the Placement Agent is not and shall not be construed as a fiduciary of the Company and shall have no duties
or liabilities to the equity holders or the creditors of the Company or any other person by virtue of this Agreement or the retention
of the Placement Agent hereunder, all of which are hereby expressly waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
9</U>. <U>CLOSING</U>. The obligations of the Placement Agent, and the closing of the sale of the Placement Securities hereunder are
subject to the accuracy, when made and on the Closing Date, of the representations and warranties on the part of the Company contained
herein and in the Purchase Agreement, to the performance by the Company of its obligations hereunder, and to each of the following additional
terms and conditions, except as otherwise disclosed to and acknowledged and waived by the Placement Agent:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
All corporate proceedings and other legal matters incident to the authorization, form, execution, delivery and validity of each of this
Agreement, the Placement Securities, and all other legal matters relating to this Agreement and the transactions contemplated hereby
with respect to the Placement Securities shall be reasonably satisfactory in all material respects to the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
The Placement Agent shall have received the favorable opinion of Sullivan &amp; Worcester LLP, counsel to the Company, in form and substance
reasonably satisfactory to the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
The Placement Agent shall have received (i) a customary Officers&rsquo; Certificate, executed and delivered by the Company&rsquo;s executive
officers, as to the accuracy of the representations and warranties contained in the Purchase Agreement, (ii) on the date hereof and on
the Closing Date, a Chief Financial Officer&rsquo;s Certificate regarding certain financial information included in the Registration
Statement and Prospectus and (iii) a Secretary&rsquo;s Certificate executed and delivered by the Company&rsquo;s corporate secretary
certifying that (A) the Company&rsquo;s charter documents are true and complete, have not been modified and are in full force and effect;
(B) that the resolutions of the Company&rsquo;s Board of Directors relating to the Placement are in full force and effect and have not
been modified; (C) as to the incumbency of the officers of the Company and (D) other customary certifications reasonably satisfactory
to the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.
The Placement Agent shall have received an executed FINRA questionnaire from each of the Company and the Company&rsquo;s executive officers,
directors and ten percent (10.0%) or greater securityholders, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.
The Placement Agent shall have received executed copies of the Lock-Up Agreement, the form of which is attached hereto as <U>Exhibit
B</U>, from each of the persons listed on <U>Schedule A</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.
The Placement Agent shall have received from each of Marcum LLP and Baker Tilly US, LLP letters, dated as of the date hereof and as of
the Closing Date, in form and substance satisfactory to the Placement Agent, together with signed or reproduced copies of such letter
for the Placement Agent containing statements and information of the type ordinarily included in accountants&rsquo; &ldquo;comfort letters&rdquo;
to underwriters with respect to the financial statements and certain financial information contained in the Registration Statement and
Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.
The Placement Agent shall have received on each Closing Date satisfactory evidence of the good standing of the Company in its jurisdiction
of organization and its good standing as foreign corporation in such other jurisdictions as the Placement Agent may reasonably request,
in each case in writing or any standard form of telecommunication from the appropriate governmental authorities of such jurisdictions,
dated no more than one (1) business day prior to such Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.
The Placement Common Stock shall be registered under the Exchange Act. The Company shall have taken no action designed to, or likely
to have the effect of terminating the registration of the Common Stock under the Exchange Act or delisting or suspending from trading
the Common Stock from the Trading Market or other applicable U.S. national exchange, nor has the Company received any information suggesting
that the Commission or the Trading Market or other U.S. applicable national exchange is contemplating terminating such registration or
listing. In addition, the Company shall have submitted a listing of additional shares notification form to the New York Stock Exchange
American (&ldquo;<B>NYSE American</B>&rdquo;) with respect to the Placement Shares and shall have received no objection thereto from
the NYSE American.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">J.
No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental
agency or body which would, as of the Closing Date, prevent the issuance or sale of the Placement Securities or materially and adversely
affect or potentially and adversely affect the business or operations of the Company; and no injunction, restraining order or order of
any other nature by any federal or state court of competent jurisdiction shall have been issued as of the Closing Date which would prevent
the issuance or sale of the Placement Securities or materially and adversely affect or potentially and adversely affect the business
or operations of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">K.
The Company shall have entered into a Purchase Agreement with each of the Purchasers of the Placement Securities and such agreements
shall be in full force and effect and shall contain representations, warranties and covenants of the Company as agreed upon between the
Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L.
FINRA shall have raised no objection to the fairness and reasonableness of the terms and arrangements of this Agreement. In addition,
the Company shall, if requested by the Placement Agent, make or authorize Placement Agent&rsquo;s counsel to make on the Company&rsquo;s
behalf, any filing with the FINRA Corporate Financing Department pursuant to FINRA Rule 5110 with respect to the Placement and pay all
filing fees required in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the conditions specified in this Section 9 shall not have been fulfilled when and as required by this Agreement, all obligations
of the Placement Agent hereunder may be cancelled by the Placement Agent at, or at any time prior to, any Closing Date. Notice of such
cancellation shall be given to the Company in writing or orally. Any such oral notice shall be confirmed promptly thereafter in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
10</U>. <U>GOVERNING LAW</U>. This Agreement will be governed by, and construed in accordance with, the laws of the State of New York
applicable to agreements made and to be performed entirely in such State, without regard to principles of conflicts of law. This Agreement
may not be assigned by either party without the prior written consent of the other party. This Agreement shall be binding upon and inure
to the benefit of the parties hereto, and their respective successors and permitted assigns. Any right to trial by jury with respect
to any dispute arising under this Agreement or any transaction or conduct in connection herewith is waived. Any dispute arising under
this Agreement may be brought into the courts of the State of New York or into the Federal Court located in New York, New York and, by
execution and delivery of this Agreement, the Company hereby accepts for itself and in respect of its property, generally and unconditionally,
the jurisdiction of aforesaid courts. Each party hereto hereby irrevocably waives personal service of process and consents to process
being served in any such suit, action or proceeding by delivering a copy thereof via overnight delivery (with evidence of delivery) to
such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
manner permitted by law. If either party shall commence an action or proceeding to enforce any provisions of this Agreement, then the
prevailing party in such action or proceeding shall be reimbursed by the other party for its attorney&rsquo;s fees and other costs and
expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
11</U>. <U>ENTIRE AGREEMENT/MISCELLANEOUS</U>. This Agreement embodies the entire agreement and understanding between the parties hereto,
and supersedes all prior agreements and understandings, relating to the subject matter hereof. Notwithstanding the foregoing, that certain
Engagement Letter, dated January 29, 2026, by and between the Company and the Placement Agent shall remain in full force and effect.
If any provision of this Agreement is determined to be invalid or unenforceable in any respect, such determination will not affect such
provision in any other respect or any other provision of this Agreement, which will remain in full force and effect. This Agreement may
not be amended or otherwise modified or waived except by an instrument in writing signed by both the Placement Agent and the Company.
The representations, warranties, agreements and covenants contained herein shall survive the Closing Date of the Placement and delivery
of the Placement Securities. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,
it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or a .pdf format file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such facsimile or .pdf signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
12</U>. <U>NOTICES</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication
is sent to the email address specified on the signature pages attached hereto prior to 6:30 p.m. (New York City time) on a business day,
(b) the next business day after the date of transmission, if such notice or communication is sent to the email address on the signature
pages attached hereto on a day that is not a business day or later than 6:30 p.m. (New York City time) on any business day, (c) the third
business day following the date of mailing, if sent by U.S. internationally recognized air courier service, or (d) upon actual receipt
by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the
signature pages hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
13</U>. <U>PRESS ANNOUNCEMENTS</U>. The Company agrees that the Placement Agent shall, on and after the Closing Date, have the right
to reference the Placement and the Placement Agent&rsquo;s role in connection therewith in the Placement Agent&rsquo;s marketing materials
and on its website and to place advertisements in financial and other newspapers and journals, in each case at its own expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SECTION
14</U>. <U>STANDSTILL</U>. Without the prior written consent of Placement Agent, from the date hereof until seventy-five (75) days after
the Closing Date, neither the Company nor any subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance
or proposed issuance of any Common Stock or common stock equivalents, other than an Exempt Issuance or (ii) file any registration statement
or any amendment or supplement thereto. For purposes of this Agreement, &ldquo;Exempt Issuance&rdquo; means the issuance of (a) shares
of Common Stock or options to employees, officers or directors of the Company pursuant to any share or option plan duly adopted for such
purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee
directors established for such purpose for services rendered to the Company, (b) securities upon the exercise or exchange of or conversion
of securities exercisable or exchangeable for or convertible into Common Stock issued and outstanding on the date of this Agreement,
provided that such securities have not been amended since the date of this Agreement to increase the number of such securities or to
decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits or combinations)
or to extend the term of such securities, (c) the securities of the Company issued pursuant to the Purchase Agreements and (d) securities
issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, provided
that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights that
require or permit the filing of any registration statement in connection therewith during the prohibition period in Section 14 herein
and provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries,
an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company
additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities
primarily for the purpose of raising capital or to an entity whose primary business is investing in securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
page follows</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
confirm that the foregoing correctly sets forth our agreement by signing and returning to the Placement Agents the enclosed copy of this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TITAN
                                            PARTNERS GROUP LLC,</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A
    DIVISION OF AMERICAN CAPITAL PARTNERS, LLC</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Adam Sands</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adam
    Sands</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
    Representative</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
for notice:</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Titan
Partners Group LLC, a division of American Capital Partners, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4
World Trade Center, 49th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10007</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy to Placement Agent&rsquo;s counsel (which shall not constitute notice) at:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mintz,
Levin, Cohn, Ferris, Glovsky and Popeo, P.C.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">919
Third Avenue</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted
and Agreed to as of the date first written above:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>ABUNDIA
    GLOBAL IMPACT GROUP, INC. </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Edward Gillespie</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Edward
    Gillespie</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
for notice</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abundia
Global Impact Group, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1300
Post Oak Blvd., Suite 1305</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Houston,
Texas 77056</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy to the Company counsel (which shall not constitute notice) at:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sullivan
&amp; Worcester LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1251
Avenue of the Americas</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10020</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>6
<FILENAME>ex10-2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of February 19, 2026, between Abundia Global Impact Group,
Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including
its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities
Act (as defined below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires
to purchase from the Company, securities of the Company as more fully described in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I.<BR>
</B>DEFINITIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms
have the meanings set forth in this Section 1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Base
Prospectus</U>&rdquo; means the prospectus included in the Registration Statement at the time it became effective, including documents
incorporated therein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the first (1st) Trading
Day following the date hereof (or the second (2nd) Trading Day following the date hereof if this Agreement is signed on a day that is
not a Trading Day or after 4:00 p.m. (New York City time) and before midnight (New York City time) on a Trading Day).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;</I><U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Counsel</U>&rdquo; means Sullivan &amp; Worcester LLP, with offices located at 1251 Avenue of Americas, 19<SUP>th</SUP> Floor, New York,
NY 10020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the
date hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight
(New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers, directors or consultants of the
Company pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of
Directors or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to
the Company, provided that any shares of Common Stock or options issued to consultants of the Company under this clause (a) are issued
as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights that require or permit the filing of
any registration statement in connection therewith during the prohibition period in Section 4.12(a) herein, (b) securities upon the exercise
or exchange of or conversion of any Securities issued hereunder and/or other securities exercisable or exchangeable for or convertible
into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended
since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion
price of such securities (other than in connection with stock splits or combinations) or to extend the term of such securities, and (c)
securities issued pursuant to license or distribution agreements, acquisitions or strategic transactions approved by a majority of the
disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in
Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith during
the prohibition period in Section 4.12(a) herein, and provided that any such issuance shall only be to a Person (or to the equityholders
of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with
the businesses of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall
not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose
primary business is investing in securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(aa).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Lock-Up
Agreement</U>&rdquo; means the Lock-Up Agreement, dated as of the date hereof, by and among the Company and the directors and executive
officers of the Company, in the form of <U>Exhibit A</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Per
Share Purchase Price</U>&rdquo; equals $3.37, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agent</U>&rdquo; means Titan Partners Group LLC, a division of American Capital Partners, LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agency Agreement</U>&rdquo; means the placement agency agreement, dated as of the date hereof, by and among the Company and the Placement
Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus</U>&rdquo;
means the Prospectus Supplement together with the Base Prospectus, including all information, documents and exhibits filed with or incorporated
by reference into such prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act including all information,
documents and exhibits filed with or incorporated by reference into such prospectus supplement, that is filed with the Commission and
delivered by the Company to each Purchaser at the Closing in connection with the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement filed with the Commission on Form S-3, as amended (File No. 333-290308),
which registers the sale of the Securities, including, without limitation, the documents incorporated by reference therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares purchased hereunder as specified below such
Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo; in United States
dollars and in immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company listed in <U>Schedule I</U> attached hereto, and any subsidiary that after the date of this Agreement
becomes &ldquo;<I>significant subsidiary</I>&rdquo; of the Company (as defined in Rule 1-02(w) of Regulation S-X under the Exchange Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Mintz</U>&rdquo;
means Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., with offices at 919 Third Avenue, New York, NY 10022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Lock-Up Agreement, the Pre-Funded Warrants all exhibits and schedules thereto and hereto
and any other documents or agreements executed in connection with the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Standard Registrar and Transfer Company, the current transfer agent of the Company, with offices located at 440
East 400 South Suite 200, Salt Lake City, Utah 84111, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURCHASE
AND SALE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Closing</U>. On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the
Purchasers, severally and not jointly, agree to purchase, (i) the number of Shares set forth under &ldquo;Subscription Amount&rdquo;
on the Purchaser&rsquo;s signature page hereto at the Per Share Purchase Price, and (ii) pre-funded warrants to purchase up to the number
of shares of Common Stock as set forth under Pre-Funded Warrants on the Purchaser&rsquo;s signature page hereto (the &ldquo;<U>Pre-Funded
Warrants</U>&rdquo;), in the form of <U>Exhibit B</U> attached hereto, in each case at a price per share of Common Stock or Pre-Funded
Warrant as set forth on the Purchaser&rsquo;s signature page hereto. Each Purchaser&rsquo;s Subscription Amount as set forth on the signature
page hereto executed by such Purchaser shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement with the Company
or its designee. The Company shall deliver to each Purchaser its respective Shares, and the Company and each Purchaser shall deliver
the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections
2.2 and 2.3, the Closing shall occur at such location as the parties shall mutually agree or take place remotely by electronic transfer
of the Closing documentation. Unless otherwise directed by the Placement Agent, settlement of the Shares shall occur via &ldquo;Delivery
Versus Payment&rdquo; (i.e., on the Closing Date, the Company shall issue the Shares directly to the account designated by the Placement
Agent, and upon receipt of such Shares, the Placement Agent shall promptly, electronically deliver such Shares to the applicable Purchaser,
and payment therefor shall be made by the Placement Agent (or its clearing firm) by wire transfer to the Company). Notwithstanding anything
herein to the contrary, if at any time on or after the time of execution of this Agreement by the Company and an applicable Purchaser,
through, and including the time immediately prior to the Closing (the &ldquo;<U>Pre-Settlement Period</U>&rdquo;), such Purchaser sells
to any Person all, or any portion, of the Shares to be issued hereunder to such Purchaser at the Closing (collectively, the &ldquo;<U>Pre-Settlement
Shares</U>&rdquo;), such Purchaser shall, automatically hereunder (without any additional required actions by such Purchaser or the Company),
be deemed to be unconditionally bound to purchase such Pre-Settlement Shares at the Closing, and the Company shall be deemed to be unconditionally
bound to sell such Pre-Settlement Shares to such Person at the Closing; provided, that the Company shall not be required to deliver any
Pre-Settlement Shares to such Purchaser prior to the Company&rsquo;s receipt of the purchase price of such Pre-Settlement Shares hereunder;
and provided further that the Company hereby acknowledges and agrees that the forgoing shall not constitute a representation or covenant
by such Purchaser as to whether or not during the Pre-Settlement Period such Purchaser shall sell any shares of Common Stock to any Person
and that any such decision to sell any shares of Common Stock by such Purchaser shall solely be made at the time such Purchaser elects
to effect any such sale, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to the Closing Date (except as indicated below), the Company shall deliver or cause to be delivered to each Purchaser the
following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
 this Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
 a legal opinion of Company Counsel, in the form reasonably acceptable to the Purchasers and
the Placement Agent, in form and substance reasonably satisfactory to Mintz;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
 the Company shall have provided each Purchaser with the Company&rsquo;s wire instructions,
on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
 subject to the last sentence of Section 2.1, a copy of the irrevocable instructions to the
Transfer Agent instructing the Transfer Agent to deliver on an expedited basis via The Depository Trust Company Deposit or Withdrawal
at Custodian system Shares equal to such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price, registered in
the name of such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
 the duly executed Lock-Up Agreements;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
 the duly executed and delivered Officer&rsquo;s Certificate, in form and substance reasonably
satisfactory to the Placement Agent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
 the duly executed and delivered Secretary&rsquo;s Certificate, in form and substance reasonably
satisfactory to the Placement Agent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii) on
the date of this Agreement and at the Closing, the duly executed Chief Financial Officers&rsquo; Certificates, in form and substance
reasonably satisfactory to the Placement Agent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix) the
Placement Agent shall have received from each of Marcum LLP and Baker Tilly US, LLP letters, dated as of the date hereof and as of the
Closing Date, in form and substance satisfactory to the Placement Agent, together with signed or reproduced copies of such letter for
the Placement Agent containing statements and information of the type ordinarily included in accountants&rsquo; &ldquo;comfort letters&rdquo;
to placement agents with respect to the financial statements and certain financial information contained in the Registration Statement
and the Prospectus;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x) the
duly executed Pre-Funded Warrants; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)
the Prospectus (which may be delivered in accordance with Rule 172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
 this Agreement duly executed by such Purchaser; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
 such Purchaser&rsquo;s Subscription Amount, which shall be made available for &ldquo;Delivery
Versus Payment&rdquo; settlement with the Company or its designee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<U>Closing Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The obligations of the Company hereunder in connection with the Closing with respect to each Purchaser are subject to the following conditions
being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects)
on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in
which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality,
in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been
performed in all material respects; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless
as of a specific date therein in which case they shall be accurate in all material respects or, to the extent representations or warranties
are qualified by materiality or Material Adverse Effect, in all respects) as of such date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
there shall have been no Material Adverse Effect with respect to the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
from the date hereof to and including the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or
the Company&rsquo;s principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported
by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades
are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States
or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international
calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable
judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
the Company shall have filed an additional listing application with the principal Trading Market with respect to the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III.<BR>
</B>REPRESENTATIONS AND WARRANTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Representations and Warranties of the Company</U>. Except as set forth in the SEC Reports, the Company hereby makes the following
representations and warranties to each Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Subsidiaries</U>. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary
free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and
are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Organization and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned
by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could
not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise)
of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in
any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material
Adverse Effect</U>&rdquo;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking
to revoke, limit or curtail such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no
further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith
other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been
(or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will
constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as
limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law. The Pre-Funded Warrants have been duly authorized and, when executed and delivered by the Company in accordance with this Agreement,
will be valid and legally binding agreements of the Company, enforceable against the Company in accordance with their terms except as
the enforcement thereof may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws relating
to or affecting the rights and remedies of creditors or by general equitable principles. The maximum number of shares to be issued by
the Company upon exercise of the Pre-Funded Warrants in accordance therewith have been duly authorized and have been or will be reserved
for issuance upon exercise of the Pre-Funded Warrants in a number sufficient to meet the current exercise requirements. The shares underlying
the Pre-Funded Warrants, when issued and delivered upon exercise of the Pre-Funded Warrants in accordance therewith, will be validly
issued, fully paid and non-assessable, and the issuance of such shares is not subject to any preemptive or similar rights not otherwise
validly waived or satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby
do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles
of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or
assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Filings, Consents and Approvals</U>. Except as set forth in <U>Schedule 3.1(e)</U>, the Company is not required to obtain any consent,
waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local,
foreign or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of
the Transaction Documents, other than: (i) the filings required pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission
of the Prospectus Supplement, (iii) the notice and/or application(s) to each applicable Trading Market for the listing of the Shares
for trading thereon in the time and manner required thereby, and (iv) such filings as are required to be made under applicable state
securities laws (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Issuance of the Securities; Registration</U>. The Shares are duly authorized and, when issued and paid for in accordance with this
Agreement, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company
has reserved and will keep available from its duly authorized but unissued shares of Common Stock, and at all times will have sufficient
authorized but unissued shares of Common Stock to accommodate the maximum number of shares of Common Stock issuable pursuant to this
Agreement. The Company has filed the Registration Statement in conformity with the requirements of the Securities Act, which automatically
became effective on November 4, 2025, including the Prospectus, and such amendments and supplements thereto as may have been required
to the date of this Agreement. The Registration Statement is effective under the Securities Act, and no stop order preventing or suspending
the effectiveness of the Registration Statement or suspending or preventing the use of the Prospectus has been issued by the Commission
and no proceedings for that purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission. The Company
shall file the Prospectus Supplement with the Commission pursuant to Rule 424(b). At the time the Registration Statement and any amendments
thereto became effective, at the date of this Agreement and at the Closing Date, the Registration Statement and any amendments thereto
conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain any untrue
statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein
not misleading; and the Base Prospectus, the Prospectus Supplement and any amendments or supplements thereto, at the time the Base Prospectus,
the Prospectus Supplement or any amendment or supplement thereto was issued and at the Closing Date, conformed and will conform in all
material respects to the requirements of the Securities Act and did not and will not contain an untrue statement of a material fact or
omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were
made, not misleading. The Company was at the time of the filing of the Registration Statement eligible to use Form S-3. The Company is
eligible to use Form S-3 under the Securities Act and meets the transaction requirements as set forth in General Instruction I.B.1 of
Form S-3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Capitalization</U>. The capitalization of the Company is as set forth in the SEC Reports as of the date thereof, which SEC Reports
also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date thereof.
The Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant
to the exercise of employee stock options under the Company&rsquo;s stock option plans, the issuance of shares of Common Stock to employees
pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents
outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal,
preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents.
Except as a result of the purchase and sale of the Securities and as set forth in the SEC Reports, there are no outstanding options,
warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations
convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common
Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary
is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The
issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities
to any Person (other than the Purchasers). There are no outstanding securities or instruments of the Company or any Subsidiary with any
provision that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities
by the Company or any Subsidiary. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any
redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any
Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation
rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital
stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal
and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to
subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others is required
for the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with
respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any
of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the
two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus, being
collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received a valid extension of such
time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC
Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of
the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated
therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.
The Company is not an issuer subject to Rule 144(i) under the Securities Act. The financial statements of the Company included in the
SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with
respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally
accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be
otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain
all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated
Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the
case of unaudited statements, to normal, immaterial, year-end audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included
within the SEC Reports, except as set forth in the SEC Reports, (i) there has been no event, occurrence or development that has had or
that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent
or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice
and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings
made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant
to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential treatment
of information. Except for the issuance of the Securities contemplated by this Agreement or as set forth in the SEC Reports, no event,
liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect
to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition that
would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made
that has not been publicly disclosed at least 1 Trading Day prior to the date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Litigation</U>. Except as set forth in the SEC Reports, there is no action, suit, inquiry, notice of violation, proceeding or investigation
pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth in the SEC Reports, (i) adversely affects or challenges
the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable
decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director
or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities
laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated,
any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission
has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary
under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe
that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary,
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local
and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that
has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor
has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator
or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental
authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational
health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be
expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Environmental Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating
to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface
strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or
toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating
to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well
as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders,
permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have
received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses;
and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and
(iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports,
except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or
modification of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them
and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment
of federal, state, foreign or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment
of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Intellectual Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which
the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None
of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights
has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date
of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included
within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe
upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge
of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any
of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy,
confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect. The Company has no knowledge of any facts that would preclude it from having
valid license rights or clear title to the Intellectual Property Rights. The Company has no knowledge that it lacks or will be unable
to obtain any rights or licenses to use all Intellectual Property Rights that are necessary to conduct its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the Company
nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase
in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Transactions With Affiliates and Employees</U>. Except as set forth in the SEC Reports, none of the officers or directors of the Company
or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to
any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract,
agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to
or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director
or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
employee benefits, including stock option agreements under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements
of the Sarbanes-Oxley Act of 2002, as amended that are effective as of the date hereof, and any and all applicable rules and regulations
promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries
maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with
management&rsquo;s general or specific authorization, and (iv) the recorded accountability for assets and liabilities is compared with
the existing assets and liabilities at reasonable intervals and appropriate action is taken with respect to any differences. The Company
and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for
the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed
by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the
time periods specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness
of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently
filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most
recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure
controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in
the internal control over financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that
have materially affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company
and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Certain Fees</U>. Except for fees payable by the Company to the Placement Agent, no brokerage or finder&rsquo;s fees or commissions
are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no
obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated
in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities,
will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Registration Rights</U>. No Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities
Act of any securities of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and
the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. Except as set forth in the SEC Reports, the Company has not, in the 12 months preceding the date hereof, received
notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance
with the listing or maintenance requirements of such Trading Market. Except as set forth in the SEC Reports, the Company is, and has
no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements.
The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation
and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in
connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the
laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company
fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of
the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or
counsel with any information that it believes constitutes or might constitute material, non-public information which is not otherwise
disclosed in the Prospectus Supplement. The Company understands and confirms that the Purchasers will rely on the foregoing representation
in effecting transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers
regarding the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby is true and correct
and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements
made therein, in the light of the circumstances under which they were made, not misleading. The press releases disseminated by the Company
during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of
the circumstances under which they were made and when made, not misleading. The Company acknowledges and agrees that no Purchaser makes
or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set
forth in Section 3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of any Trading Market
on which any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>Solvency</U>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt
by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known
contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its
business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)
the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature
(taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any
facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from the Closing Date. The SEC Reports set forth as of the date thereof all outstanding secured
and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes
of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed money or amounts owed in excess of $50,000
(other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent
obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s consolidated
balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar
transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $50,000 due under leases
required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Tax Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income
and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii)
has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such
returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material
taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material
amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no
basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
<U>Foreign Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any
agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
<U>Accountants</U>. Marcum LLP, whose report on the balance sheets of the Company as of December 31, 2024 and 2023, the related statement
of operations, stockholders&rsquo; equity (deficit), and cash flows each of the two years in the period ended December, 2024, and the
related notes, is filed with the Company&rsquo;s annual report on Form 10-K, are and, during the periods covered by their report, were
independent public accountants within the meaning of the Securities Act and the Public Company Accounting Oversight Board (United States)
(&ldquo;<U>PCAOB</U>&rdquo;). The Company&rsquo;s current registered public accounting firm is CBIZ CPAs P.C.. To the knowledge of the
Company, such accounting firm is an independent registered public accounting firm with respect to the Company and its Subsidiaries within
the applicable rules and regulations adopted by the Commission and the PCAOB and as required by the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
<U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives. The Company has not relied upon the Placement Agent or any of
its Affiliates or representatives for any legal, tax or accounting advice in connection with the offering and sale of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>Acknowledgment Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Sections 3.2(f) and 4.14 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been
asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the
Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified
term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales
or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private placement transactions, may negatively
impact the market price of the Company&rsquo;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage
in hedging activities at various times during the period that the Securities are outstanding, and (z) such hedging activities (if any)
could reduce the value of the existing stockholders&rsquo; equity interests in the Company at and after the time that the hedging activities
are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction
Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>Regulation M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement
of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>No Disagreements with Accountants and Lawyers</U>. There are no disagreements of any kind presently existing, or reasonably anticipated
by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company, and the Company
is current with respect to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any
of its obligations under any of the Transaction Documents or the Placement Agency Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Cybersecurity</U>. To the Company&rsquo;s knowledge, (i)(x) there has been no security breach or other compromise of or relating to
any of the Company&rsquo;s or any Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data
(including the data of its respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of
it), equipment or technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have not
been notified of, and has no knowledge of any event or condition that would reasonably be expected to result in, any security breach
or other compromise to its IT Systems and Data; (ii) the Company and the Subsidiaries are presently in compliance with all applicable
laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority,
internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such
IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate,
have a Material Adverse Effect; (iii) the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards
to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security of all
IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent with
industry standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
<U>Compliance with Data Privacy Laws</U>. To the Company&rsquo;s knowledge: (i) the Company and the Subsidiaries are, and at all times
during the last three (3) years were, in compliance with all applicable state, federal and foreign data privacy and security laws and
regulations, including, without limitation, the European Union General Data Protection Regulation (&ldquo;<U>GDPR</U>&rdquo;) (EU 2016/679)
(collectively, &ldquo;<U>Privacy Laws</U>&rdquo;); (ii) the Company and the Subsidiaries have in place, comply with, and take appropriate
steps reasonably designed to ensure compliance with their policies and procedures relating to data privacy and security and the collection,
storage, use, disclosure, handling and analysis of Personal Data (as defined below) (the &ldquo;<U>Policies</U>&rdquo;); (iii) the Company
provides accurate notice of its applicable Policies to its customers, employees, third party vendors and representatives as required
by the Privacy Laws; and (iv) applicable Policies provide accurate and sufficient notice of the Company&rsquo;s then-current privacy
practices relating to its subject matter, and do not contain any material omissions of the Company&rsquo;s then-current privacy practices,
as required by Privacy Laws. &ldquo;<U>Personal Data</U>&rdquo; means (i) a natural person&rsquo;s name, street address, telephone number,
email address, photograph, social security number, bank information, or customer or account number; (ii) any information which would
qualify as &ldquo;personally identifying information&rdquo; under the Federal Trade Commission Act, as amended; (iii) &ldquo;personal
data&rdquo; as defined by GDPR; and (iv) any other piece of information that allows the identification of such natural person, or his
or her family, or permits the collection or analysis of any identifiable data related to an identified person&rsquo;s health or sexual
orientation. Except as would not, individual or in the aggregate, have a material adverse effect: (i) none of such disclosures made or
contained in any of the Policies have been inaccurate, misleading, or deceptive in violation of any Privacy Laws; and (ii) the execution,
delivery and performance of the Transaction Documents will not result in a breach of any Privacy Laws or Policies. Neither the Company
nor the Subsidiaries, to the knowledge of the Company, (i) has received written notice of any actual or potential liability of the Company
or the Subsidiaries under, or actual or potential violation by the Company or the Subsidiaries of, any of the Privacy Laws; (ii) is currently
conducting or paying for, in whole or in part, any investigation, remediation or other corrective action pursuant to any regulatory request
or demand pursuant to any Privacy Law; or (iii) is a party to any order, decree, or agreement by or with any court or arbitrator or governmental
or regulatory authority that imposed any obligation or liability under any Privacy Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance
with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the
Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the
Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company
policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the
release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or
prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity
of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
<U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Representations and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and
warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case
they shall be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and
in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to
which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof,
will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except:
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Understandings or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct
or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities in violation
of the Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser&rsquo;s right
to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities
laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Purchaser Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is an &ldquo;accredited
investor&rdquo; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of
an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the
Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition,
results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the
opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that
is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither
the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect
to the Securities nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes
any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public
information with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance of the
Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to
such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has
not directly or indirectly executed any purchases or sales, including Short Sales, of the securities of the Company while in possession
of material non-public information during the period commencing as of the time that such Purchaser first received a term sheet (written
or oral) from the Company or any other Person representing the Company setting forth the material terms of the transactions contemplated
hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, (A) in the case of a Purchaser that is
a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets, the
representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the
investment decision to purchase the Securities covered by this Agreement, and (B) in the case of a Purchaser that has implemented internal
information barriers pursuant to information controls policy to &ldquo;wall-off&rdquo; certain trading personnel, the representations
set forth above shall only apply to such walled-off trading personnel. Other than to other Persons party to this Agreement or to such
Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners, legal and other advisors, employees,
agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction
(including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV.<BR>
</B>OTHER AGREEMENTS OF THE PARTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Legends</U>. The Shares shall be issued free of all restrictive legends.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Furnishing of Information</U>. Until the time that no Purchaser owns Securities, the Company covenants to maintain the registration
of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and timely file (or obtain extensions in respect thereof and file
within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act
even if the Company is subject to the reporting requirements of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security
(as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the
rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction
unless shareholder approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Securities Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material
terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits
thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company
represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers
by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including,
without limitation, the Placement Agent, in connection with the transactions contemplated by the Transaction Documents. In addition,
effective upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations
under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors,
agents, employees, Affiliates or agents, including, without limitation, the Placement Agent, on the one hand, and any of the Purchasers
or any of their Affiliates on the other hand, shall terminate and be of no further force or effect. The Company understands and confirms
that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and
each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby,
and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the
prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with
respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is
required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement
or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name
of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such
Purchaser, except (a) as required by federal securities law in connection with the filing of final Transaction Documents with the Commission
and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers
with prior notice of such disclosure permitted under this clause (b) and reasonably cooperate with such Purchaser regarding such disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Shareholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person,
that any Purchaser is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill
(including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by
the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving
Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Non-Public Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting
on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing to the receipt of such
information and agreed in writing with the Company to keep such information confidential. The Company understands and confirms that each
Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company,
any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public
information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall
not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees,
Affiliates or agents, including, without limitation, the Placement Agent, or a duty to the Company, any of its Subsidiaries or any of
their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, not to trade
on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent
that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the
Company or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice with the Commission pursuant
to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant
in effecting transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Use of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities hereunder as described in the Prospectus
Supplement and shall not use such proceeds: (a) for the satisfaction of any portion of the Company&rsquo;s debt (other than payment of
trade payables in the ordinary course of the Company&rsquo;s business and prior practices and as described in the Prospectus Supplement),
(b) for the redemption of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in
violation of FCPA or OFAC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Indemnification of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser
and its directors, officers, shareholders, members, partners, investment managers, employees and agents (and any other Persons with a
functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who
controls such Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors,
officers, shareholders, agents, members, partners, investment managers, or employees (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser
Party</U>&rdquo;) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including
all judgments, amounts paid in settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such
Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants
or agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser
Parties in any capacity (including a Purchaser Party&rsquo;s status as an investor), or any of them or their respective Affiliates, by
the Company or any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions
contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party&rsquo;s
representations, warranties or covenants under the Transaction Documents or any conduct by such Purchaser Party which is finally judicially
determined to constitute fraud, gross negligence or willful misconduct). If any action shall be brought against any Purchaser Party in
respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing,
and, except with respect to direct claims brought by the Company, the Company shall have the right to assume the defense thereof with
counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate
counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense
of such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing,
(ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action there
is, in the reasonable opinion of counsel to the applicable Purchaser Party (which may be internal counsel), a material conflict on any
material issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible
for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party
under this Agreement (y) for any settlement by a Purchaser Party effected without the Company&rsquo;s prior written consent, which shall
not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable
to any Purchaser Party&rsquo;s breach of any of the representations made by the Purchaser in this Agreement. Company shall not, without
the prior written consent of the Purchaser Party, effect any settlement of any pending or threatened action or proceeding in respect
of which any Purchaser Party is or could have been a party and indemnity could have been sought hereunder by such Purchaser Party, unless
such settlement includes an unconditional release of such Purchaser Party from all liability on claims that are the subject matter of
such proceeding and does not include any statements as to, or any findings of, fault, culpability or failure to act by or on behalf of
any Purchaser Party. In addition, if any Purchaser Party takes actions to collect amounts due under any Transaction Documents or to enforce
the provisions of any Transaction Documents, then the Company shall pay the costs incurred by such Purchaser Party for such collection,
enforcement or action, including, but not limited to, attorneys&rsquo; fees and disbursements. The indemnification and other payment
obligations required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course of the investigation,
defense, collection, enforcement or action, as and when bills are received or are incurred. The indemnity agreements contained herein
shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities
the Company may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
<U>Reservation of Common Stock</U>. As of the date hereof, the Company has reserved, free of preemptive rights, a sufficient number of
shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
<U>Listing of Common Stock</U>. The Company hereby agrees to use its best efforts to maintain the listing or quotation of the Common
Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote
all of the Shares on such Trading Market and to promptly secure the listing of all of the Shares on such Trading Market. The Company
further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application
all of the Shares, and will take such other action as is necessary to cause all of the Shares to be listed or quoted on such other Trading
Market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing and trading of its
Common Stock on a Trading Market and will comply in all respects with the Company&rsquo;s reporting, filing and other obligations under
the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer
through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of
fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11
[RESERVED]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12
<U>Subsequent Equity Sales</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
From the date hereof until 75 days after the Closing Date, neither the Company nor any Subsidiary shall, without prior written consent
of the Purchasers, (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common
Stock or Common Stock Equivalents, including pursuant to any equity line of credit, or (ii) file any registration statement or amendment
or supplement thereto, other than the Prospectus Supplement or filing a registration statement on Form S-8 in connection with any employee
benefit plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Notwithstanding the foregoing, this Section 4.12 shall not apply in respect of an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13
<U>Equal Treatment of Purchasers</U>. No consideration (including any modification of the Transaction Documents) shall be offered or
paid to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration
is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat
the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the
purchase, disposition or voting of Securities or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14
<U>Certain Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that
neither it nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including
Short Sales of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at
such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as
described in Section 4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the
transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described
in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction (other than as disclosed
to its legal and other representatives). Notwithstanding the foregoing and notwithstanding anything contained in this Agreement to the
contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that
it will not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this
Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4, (ii) no Purchaser shall be
restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws
from and after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press
release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade in the securities
of the Company to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates, or agent,
including, without limitation, the Placement Agent, after the issuance of the initial press release as described in Section 4.4. Notwithstanding
the foregoing, (A) in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate
portions of such Purchaser&rsquo;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed
by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement, and (B) in the case
of a Purchaser that has implemented internal information barriers pursuant to information controls policy to &ldquo;wall-off&rdquo; certain
trading personnel, this Section 4.14 shall apply only with respect to activities of such walled-off trading personnel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15
<U>Lock-Up Agreements</U>. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except
to extend the term of the lock-up period and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If
any party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use its reasonable best efforts
to seek specific performance of the terms of such Lock-Up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16
<U>Capital Changes</U>. Until the ninety (90) day anniversary of the Closing Date, the Company shall not undertake a reverse or forward
stock split or reclassification of the Common Stock without the prior written consent of the Purchasers holding a majority in interest
of the Shares, provided that no consent shall be required in the event the Company undertakes a reverse stock split for purposes of maintaining
the listing of the Common Stock on the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V.<BR>
</B>MISCELLANEOUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Termination</U>. This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without
any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the
Closing has not been consummated on or before the fifth (5th) Trading Day following the date hereof; <U>provided</U>, <U>however</U>,
that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Fees and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including,
without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice
delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus
Supplement, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior
agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such
documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is
delivered via email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New
York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered
via email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later
than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S.
nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given.
The address for such notices and communications shall be as set forth on the signature pages attached hereto. To the extent that any
notice provided pursuant to any Transaction Document constitutes, or contains, material, nonpublic information regarding the Company
or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares based on
the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver, by
the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately
and adversely impacts a Purchaser (or multiple Purchasers), the consent of such disproportionately impacted Purchaser (or multiple Purchasers)
shall also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed
to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement
hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.
Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser
relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected
Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the
transferred Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers&rdquo; (other than in respect
of a transfer pursuant to an effective registration statement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<U>No Third-Party Beneficiaries</U>. The Placement Agent shall be the third party beneficiary of the representations, warranties, and
covenants of the Company in this Agreement and the representations, warranties, and covenants of the Purchasers in this Agreement. This
Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the
benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section
5.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto
or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of
any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient
venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction
Documents, then, in addition to the obligations of the Company under Section 4.8, the prevailing party in such Action or Proceeding shall
be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such Action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions
of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14
<U>Replacement of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
<U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction
Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that
a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16
<U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by
or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17
<U>Independent Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document
are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other
Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as
a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way
acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of
this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional
party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation
of the Transaction Documents. For reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to
communicate with the Company through Mintz. Mintz does not represent any of the Purchasers and only represents the Placement Agent. The
Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not
because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained
in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company
and the Purchasers collectively and not between and among the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18
<U>Liquidated Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts
have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19
<U>Saturdays, Sundays, Holidays, etc. </U>If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20
<U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each
and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21
<B><U>WAIVER OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY,
THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ABUNDIA
    GLOBAL IMPACT GROUP, INC.</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for Notice:</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1300
    Post Oak Blvd., Suite 1305</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Houston,
    Texas 77056</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; width: 45%"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Edward
    Gillespie</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>With
a copy to (which shall not constitute notice):</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sullivan
&amp; Worcester LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1251
Avenue of the Americas, New York, NY 10020</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn.:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emai:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURE
PAGE FOR PURCHASER FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[PURCHASER
SIGNATURE PAGES TO AGIG SECURITIES PURCHASE AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Purchaser: ________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Purchaser</I>: _________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _______________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
Address of Authorized Signatory: _________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Notice to Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Delivery of Securities to Purchaser (if not same as address for notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
Amount: $_________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares:
_________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Funded
Warrants: _________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIN
Number: ____________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to
purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the
Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii)
the Closing shall occur on the first (1st) Trading Day following the date of this Agreement (or the second (2nd) Trading Day following
the date of this Agreement if this Agreement is signed on a day that is not a Trading Day or after 4:00 p.m. (New York City time) and
before midnight (New York City time) on a Trading Day) and (iii) any condition to Closing contemplated by this Agreement (but prior to
being disregarded by clause (i) above) that required delivery by the Company or the above-signed of any agreement, instrument, certificate
or the like or purchase price (as applicable) shall no longer be a condition and shall instead be an unconditional obligation of the
Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or the like or purchase price (as applicable)
to such other party on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGES CONTINUE]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>ex99-1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Abundia
Global Impact Group Announces Pricing of $20 Million Registered Direct Offering of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>HOUSTON,
TX &mdash; February 19, 2026</B> &mdash; Abundia Global Impact Group, Inc. (NYSE: AGIG) (&ldquo;Abundia&rdquo; or the &ldquo;Company&rdquo;),
a low-carbon energy solutions company focused on converting biomass and plastics waste into high-value low-carbon fuels, today announced
that it has entered into a securities purchase agreement with a new fundamental institutional investor for the purchase and sale of 5,934,718
shares of common stock (or pre-funded warrants in lieu thereof) in a registered direct offering. The offering is expected to result in
gross proceeds of approximately $20 million, before deducting offering expenses. The closing of the offering is expected to occur on
or about February 23, 2026, subject to the satisfaction of customary closing conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company intends to use the net proceeds from this investment to complete the Front-End Engineering and Design (FEED) study, finalize
the acquisition of RPD Technologies, reduce debt, initiate construction of its innovation hub, and for working capital and general corporate
purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Titan
Partners, a division of American Capital Partners, is acting as the sole placement agent for the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Today&rsquo;s
financing represents an important milestone for Abundia as we advance toward commercial deployment,&rdquo; said Ed Gillespie, Chief Executive
Officer of Abundia. &ldquo;This transaction will meaningfully de-risks our near-term objectives and is expected to fully fund the completion
of our FEED study, the advancement of the RPD Technologies acquisition, and the accelerated development of our innovation hub. Together,
these initiatives represent critical value inflection points as we build a scalable platform for long-term growth.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
offering is being made in the United States pursuant to an effective shelf registration statement on Form S-3 (File No. 333-290308) previously
filed with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) that became effective on November 3, 2025. The offering
is made only by means of a prospectus supplement, which will be filed with the SEC and will be available on the SEC&rsquo;s website located
at www.sec.gov. Electronic copies of the prospectus supplement may be obtained, when available, by contacting Titan Partners Group LLC,
a division of American Capital Partners, LLC, 4 World Trade Center, 49th Floor, New York, NY 10007, by phone at (929) 833-1246 or by
email at prospectus@titanpartnersgrp.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities
in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Abundia Global Impact Group, Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abundia
Global Impact Group, Inc. (NYSE: AGIG), formerly Houston American Energy Corp., is a low-carbon energy company focused on converting
waste into value. Headquartered in Houston, Texas, we are developing commercial-scale facilities that transform waste plastics and biomass
into drop-in fuels and low-carbon chemical feedstocks. Our flagship project at Cedar Port positions Abundia at the center of the Gulf
Coast&rsquo;s energy and chemical infrastructure, with access to feedstock supply chains, upgrading partners, and end markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information, please visit <U>www.abundiaimpact.com</U><B>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains &ldquo;forward-looking information&rdquo; and &ldquo;forward-looking statements&rdquo; (collectively, &ldquo;forward-looking
information&rdquo;) within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange
Act of 1934, as amended. Forward-looking information generally is accompanied by words such as &ldquo;believe,&rdquo; &ldquo;may,&rdquo;
&ldquo;will,&rdquo; &ldquo;could,&rdquo; &ldquo;intend,&rdquo; &ldquo;expect,&rdquo; &ldquo;plan,&rdquo; &ldquo;predict,&rdquo; &ldquo;potential&rdquo;
and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Forward-looking
information is based on management&rsquo;s current expectations and beliefs and is subject to a number of risks and uncertainties that
could cause actual results to differ materially from those described in the forward-looking statements. Forward-looking information in
this press release includes, but is not limited to, statements about the amount of proceeds from the offering and use of such proceeds.
Actual results may differ materially from those indicated by these forward-looking statements as a result of a variety of factors, including,
but not limited to: (i) risks and uncertainties impacting the Company&rsquo;s business including, risks related to its current liquidity
position and the need to obtain additional financing to support ongoing operations, the Company&rsquo;s ability to continue as a going
concern, the Company&rsquo;s ability to maintain the listing of its common stock on NYSE American, the Company&rsquo;s ability to predict
its rate of growth, and (ii) other risks as set forth from time to time in the Company&rsquo;s filings with the U.S. Securities and Exchange
Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Readers
are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements are provided for illustrative
purposes only and are not intended to serve as a guarantee, an assurance, a prediction or a definitive statement of fact or probability.
Actual events and circumstances are beyond the control of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to the forward-looking information contained in this news release, the Company has made numerous assumptions. While the Company
considers these assumptions to be reasonable, these assumptions are inherently subject to significant business, economic, competitive,
market and social uncertainties and contingencies. Additionally, there are known and unknown risk factors which could cause the Company&rsquo;s
actual results, performance or achievements to be materially different from any future results, performance or achievements expressed
or implied by the forward-looking information contained herein. A complete discussion of the risks and uncertainties facing the Company&rsquo;s
business is disclosed in our Annual Report on Form 10-K and other filings with the SEC on <U>www.sec.gov</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation
to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking
information contained herein to reflect future results, events or developments, except as required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investors:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CORE
IR<BR>
<U>IR@abundiaglobalimpactgroup.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>8
<FILENAME>ex99-2.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Abundia
Global Impact Group Announces Closing of $20 Million Registered Direct Offering of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>HOUSTON,
TX &mdash; February 23, 2026</B> &mdash; Abundia Global Impact Group, Inc. (NYSE: AGIG) (&ldquo;Abundia&rdquo; or the &ldquo;Company&rdquo;),
a low-carbon energy solutions company focused on converting biomass and plastics waste into high-value low-carbon fuels, today announced
the closing of its registered direct offering pursuant to a securities purchase agreement with a new fundamental institutional investor
for the purchase and sale of 5,934,718 shares of common stock (or pre-funded warrants in lieu thereof) in a registered direct offering.
The gross proceeds to the Company were approximately $20 million, before deducting offering expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company intends to use the net proceeds from this investment to complete the Front-End Engineering and Design (FEED) study, finalize
the acquisition of RPD Technologies, reduce debt, initiate construction of its innovation hub, and for working capital and general corporate
purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Titan
Partners, a division of American Capital Partners, acted as the sole placement agent for the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
offering was made in the United States pursuant to an effective shelf registration statement on Form S-3 (File No. 333-290308) previously
filed with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) that became effective on November 3, 2025. The offering
was made only by means of a prospectus supplement, which was filed with the SEC and is available on the SEC&rsquo;s website located at
www.sec.gov. Electronic copies of the prospectus supplement may be obtained, when available, by contacting Titan Partners Group LLC,
a division of American Capital Partners, LLC, 4 World Trade Center, 49th Floor, New York, NY 10007, by phone at (929) 833-1246 or by
email at prospectus@titanpartnersgrp.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities
in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Abundia Global Impact Group, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Abundia
Global Impact Group, Inc. (NYSE: AGIG), formerly Houston American Energy Corp., is a low-carbon energy company focused on converting
waste into value. Headquartered in Houston, Texas, we are developing commercial-scale facilities that transform waste plastics and biomass
into drop-in fuels and low-carbon chemical feedstocks. Our flagship project at Cedar Port positions Abundia at the center of the Gulf
Coast&rsquo;s energy and chemical infrastructure, with access to feedstock supply chains, upgrading partners, and end markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
more information, please visit <U>www.abundiaimpact.com</U><B>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains &ldquo;forward-looking information&rdquo; and &ldquo;forward-looking statements&rdquo; (collectively, &ldquo;forward-looking
information&rdquo;) within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange
Act of 1934, as amended. Forward-looking information generally is accompanied by words such as &ldquo;believe,&rdquo; &ldquo;may,&rdquo;
&ldquo;will,&rdquo; &ldquo;could,&rdquo; &ldquo;intend,&rdquo; &ldquo;expect,&rdquo; &ldquo;plan,&rdquo; &ldquo;predict,&rdquo; &ldquo;potential&rdquo;
and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Forward-looking
information is based on management&rsquo;s current expectations and beliefs and is subject to a number of risks and uncertainties that
could cause actual results to differ materially from those described in the forward-looking statements. Forward-looking information in
this press release includes, but is not limited to, statements about the use of proceeds from the offering. Actual results may differ
materially from those indicated by these forward-looking statements as a result of a variety of factors, including, but not limited to:
(i) risks and uncertainties impacting the Company&rsquo;s business including, risks related to its current liquidity position and the
need to obtain additional financing to support ongoing operations, the Company&rsquo;s ability to continue as a going concern, the Company&rsquo;s
ability to maintain the listing of its common stock on NYSE American, the Company&rsquo;s ability to predict its rate of growth, and
(ii) other risks as set forth from time to time in the Company&rsquo;s filings with the U.S. Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Readers
are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements are provided for illustrative
purposes only and are not intended to serve as a guarantee, an assurance, a prediction or a definitive statement of fact or probability.
Actual events and circumstances are beyond the control of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to the forward-looking information contained in this news release, the Company has made numerous assumptions. While the Company
considers these assumptions to be reasonable, these assumptions are inherently subject to significant business, economic, competitive,
market and social uncertainties and contingencies. Additionally, there are known and unknown risk factors which could cause the Company&rsquo;s
actual results, performance or achievements to be materially different from any future results, performance or achievements expressed
or implied by the forward-looking information contained herein. A complete discussion of the risks and uncertainties facing the Company&rsquo;s
business is disclosed in our Annual Report on Form 10-K and other filings with the SEC on <U>www.sec.gov</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation
to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking
information contained herein to reflect future results, events or developments, except as required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investors:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CORE
IR<BR>
<U>IR@abundiaglobalimpactgroup.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !5 Q<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "LO2;[[?<WTBMF)9 J?0#K^-,\1ZA]@TI]IQ
M++\B_P!37 )XUCT#3;FVM0);]V&,_=CXZGU/M73"E^YE-^B,*:J8C&PPU%7>
MK?W=3TBYU6VMK^WL2V^ZG/RQ+R0.I8^@XJ]7G?PVM+B^GOM?OG:6:0^4COR3
MW8_R'YUZ!Y\7G>3YJ>;C.S<-V/7%<[1Z>,H0P]7V47=K=^?_  "2BBBD<844
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-RL2(PE:<J3N4'ICWKAO@+.\?CJXB#'9+9.&'KAE(K,^-/\ R4R^_P"N4/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6 )DQP"W!8=A@=JW].6)?'^H_8=@MC81?:!%C;YNYMN<<9V_IB@#J**** $
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M)'!_JD>%2(_]T8XHHH L-;0.^]H(V?88]Q0$[3U7Z>U/1$BC6.-51% 5548
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GAC$*E8@B ; >H'H*** %2TMH_*V6\2^3D1[4 V9ZX],T444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ex5-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  / 9X# 2(  A$! Q$!_\0
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M1H]X"DGVQ4MUX?L[JX:8M+'OQO6-L!_J*]!U:%UI^'I_P3QU0Q=G[W7OZ_\
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7J4K.R_#^K$0I8A23;T]=M7OIKI9'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>agig-20260219.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaiOWbP9z5Z8GekhvWB/bckaDyUrriWpTyeKQgUGYU4F -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:AGIG="http://abundiaimpact.com/20260219" elementFormDefault="qualified" targetNamespace="http://abundiaimpact.com/20260219">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://abundiaimpact.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="agig-20260219_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="agig-20260219_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>agig-20260219_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>agig-20260219_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="agig-20260219.xsd#Cover" roleURI="http://abundiaimpact.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://abundiaimpact.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 19, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 19,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-32955<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ABUNDIA
GLOBAL IMPACT GROUP, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001156041<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">76-0675953<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1300
Post Oak Blvd.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Houston<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77056<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">713<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">322-8818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AGIG<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abundiaimpact.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>agig-20260219.xsd</File>
    <File>agig-20260219_lab.xml</File>
    <File>agig-20260219_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>21
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "AGIG",
   "nsuri": "http://abundiaimpact.com/20260219",
   "dts": {
    "schema": {
     "local": [
      "agig-20260219.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "agig-20260219_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "agig-20260219_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://abundiaimpact.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2026-02-19",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2026-02-19",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://abundiaimpact.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>22
<FILENAME>0001493152-26-007761-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-26-007761-xbrl.zip
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M #5Y2,KGP7LH ?5N8>FQW68&$ >$3K=#@" 1A-I1/D&:TXCQ9]9XW&'&MF(
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MHY6[ L!J2W5]JS"(3K<Y,K[\K;[V-.1?[J)'88H +R389:Z'?IM)??AO:H)
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M7U!>PZC'DK.8&29FG^P=HF*$5W.NLH-"1DGV_,(:)GROJ(LTM;?=^3HNM]U
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MT%/XI@A0'!H?U#<*@3%4A.FB<Z3KUAYP;ZHMOG&_W-M8[9'_ 5!+ P04
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M;1VB.Z>0;&5#6M2[+Z.\@9&#W=Q1YP'@YA/PMJ)(P [5TX]I=IV8Z$*8".'
MZMW],2]PO"+8EX* 09Z3$ZN!G=( JRZR5$\2 Y 7I3(SE-Z%FN@"U($L32Q*
M\33]'C# :56*H5.BSN!5A"@#B  5@O.'*5#&Q"4](,C:Q(20^ZXD P3#3@!@
MI$65\]-%-9W"+LVJ1"W<BZW3J9\V[BX(=5I'B=L"SPO6R'#M$01K44[#J2R
M2H">,U!Y<& X2D).'$S-0$2G4T(2(% #>#%K2*\==0"$EEWC,X3\>0S37P.
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M'1V? 2)[+2[L;+@J?\/:DHV[:6ZK*:M?"-/OV=845B^:PH-ZNL3\$-!GN/L
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MEZ6DFA*W>+%330G(OGZ=HY,$"MH*5@B6F*N7S>=5:N.VK@%36-9QD8$]E2(
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M4U'N<)APF4&H]/5[V*YX2FEN= VG=/' SB[!%?(-:W:1V^;[00-B%*NWY8K
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MX7,,22,BQ?&3R:<QM^)U)2U4IH<TB%FLMG O>%M>XCY"_CUMV\N[E\N8W58
M3>UX;>8N<OZJ]"6$:5TCKB.9N+'LY8PVAN8;Y]7ZB%@7$U"[D&#WL'*!#Z:\
M\6,I=NO(74BFJ.4"8U@P,L'3;O^ ?TVIU8WL(7VN;Z/]KCWR5D#.=;',1<I<
M/;9(8KX=%I!F(@Z_8IN(&(D$+ZR-7*9>QS1>%0\7U2C;Y).I7R7>U31'NLY$
M(5JAZ=5Z74^!;Q6Q,S.)#0$[FM9;FU$9I;3A:]-,A/%[3+BEC,%5A.^O[Y1:
MK^8^4T\7ES4N3(O2UV-,\@\>M:QK2Z-[:&;KH"G=;^_ITVW6\W6>H\"HLU?I
M)VQOPB(+PAO2[+?FR*5P_6[FO%(_BZH\N.R)NB\0<H$LSJ*P3?_>4W%2LGY6
MIQX75'<LF:4<]0"?<.Z,.N'^O%O^3@'N]NN:_<[<0]NN4<3 IB-0:1TE59#"
MY@0JHB*"9)/@*5H== =&U8XI$*5;@2937#.NBR7\CGL&2.2<7[Y^854_8]F
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MM=LBO "?@_B+RVR1<(L$"CAB2<OOJE$Q0/A!UK TU/V%F=P#/&G!9"!D:J_
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M'Z'JN.D5 ]?$I>"IL@8KT3636%6?&@-),+( Z_0/+!OM\UTK;Z,.&ZW3SW)
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M976-U(Q1\-]>H*CV1"H6X6L)H5[#Q#T"QT_#IG/12JWT\> D2ND*;109@8[
ME+II)=3,PP>Y!3YJ>.](O;55M,F:4-4][!PB-]_?&\F2],-S-Q#_4"9*VD2G
MOF*M"0B-E-/8)M\K]F5$]2+=?UF3!R-U3/]:XCT2@ECO"]/=D-F!3.YQ-FF8
MG]8RU?<(/PGL0O8)^15!$\6_.[Q1>V@O\>RJRA=JX"^J;M9BRQ-N]>+))UB7
MH8-,LA&1[??V-1;E2RHL%0YB'+]3<@5V^/N;&QO+*VT!V)8U%=)JY45>,A,
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M0B#8TZS(KGO,#QRD""<X)XMY -A,;]T25(+[8H3=Q9?19/)T!![WT26B?8N
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MFJ&#$%79P/J"ZT/42.Y*<7I-AR,5_R:73% 3"1AA@+(LHE=/=Y[]2<?" Q(
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M-.*Q+7:@6-0\*[T*-:IV$1<-3\62T/ @])(7B':7YH@"Q3=("NI@ /P@T83
M$ZN<"^@A#IN-,<I$2#.1>A5+H^DX(4\PZSUN&:?6:[X^I\*,/55![+:#>I(I
M4LDN%(K]F2:B7Q;O':SHM,<Q3 @N KAZ#K1ORSPC"CKX"<2X5Y[^X-J>37HS
MC#:'*,\T*I?3E&N#'<&^A&I%.X,!\/'L-#M?,A5:F=KPM?$D,<I*9;?4D*2,
MSQ:NX,E;-5PS:S-?]RBLED"+I7^SS.I>!I/.KW3.2#'GR %[ KA@52_0JPBI
M;46<EN;)GI929GE_Z^<A&PA1M9E0\\J:I&=XND,:.VH&*UMIH:>JQW\E&8()
M$ON!.4.?LHR)WFX%;>4%<YI$H'#(, 3MB)N['>$@#N@=6I.R5B8%ZGIV?S56
MY5-_^/?!431Z%_WWR='G:'PT[.^3=8$(]D'4/_@<]??&P]&!N=_)<-R+1D?1
MX=%H;S" 8US$/S$7#X_?#O&'T>[1Z.3]AW&T^QF_.^P?C<V_WO>'!\=C_&0T
M_F">B9_WNAWS!_Y[.#B.!OV]#]'?#D:?S+WWX?*WY@GCP0'<M[^__]F\VRB"
M"]X?#?KC@;G?X!_P=70X./HX'(\';_&IAX?[PST\<N[W/YEM?7 T@(]WCT?[
M)^,!W.;D8&]T\'9H[]OM#(^.!G\?P57TW,$_#H\&Q\?F+^RCX^C=R/S M!O[
M"!X#/49. DAKM3/\^RB=#7_=.I;ZH&[G$/WU=TB+OOV?/P^_T; \_'M]3>SF
M51N[><C8S:LV=K/Y%N<;[:G#@V[GTW!\8':,Z!/L-Z-WO::"+$ID0*C>,3T)
M"E9"SCXK'N03E]-K5Y9$N33?G8^7BXNB!#$'(FR/%P6JFL36=4._["PK*T!P
M(6<*>-.GQ66+KUH7@F%G:+5A#0WOO5_.L[LK[?-/:%Z4%;[[ QKL]4]BK(R-
MWAO!^QS\UT_/[]UX;1J_:C3M"V,XY EWQ=,L#[XPO5"4O/G9KV";:;H$/]=7
M/+1RZ^Z)<4W[U(/O]T>[QMT<?C138FS<WM')8<_XQ'L[@<^)6Y+K]/MW].^]
M_D<;J#[Q\E"7P4G\ ,MBWH1C@F[">JZM=LI\VRGS[,73I]1?AX79AT?Q%_.,
MRV0'(M"9V9[-]Z_:Z=-.GQ73YT,!)3- N01]-DY_,][=Z]=/7_WEF\Z9K_4_
M7OWI!QRRW>O:?O [>O+FH[KMZ9?8U;_S67RO%P]WJY>O__2(SO^:3?L?<*YC
M_.0A/=(?K0,'"21OV.T'YH]JGJ6MB_\=!P08M[ZM0]\.RFV#,@9$>&MG?D</
M[EUDZ1EU&#/[7:;1B.BHU\G<^(N- ^V;%.!;E<-YY!=P>8,-BX<.?P5"&:B+
M(:KE FC7$9]GD1VJH(9H2+;??+LLW^.\LPS7!K_%\7(ZS2[CO-OY<SR;_Q)]
MPA)<P(3L[Q]N[%L]>_[J6;?3)YIR3J/T9^;'D]A<!?<ABOJ#SQ!<?_YT8U^T
MOUCD.V\VMOG@IFUNZU=L$AL$5?CGT>!C?WCP=G#4[8S>18?]]P,?M1/M#]Z-
MH]W]_L'?-A6.<3Q\?] ?GQP-NAU\OW< @SHYVOO0/QX<F;_V]T>?CO]G4]_N
M:\ F?_FQ("8>G$3ZZ\=!@7RC.;<QK?^G7?S=CK4-:/J. :+8?S]\'QT/]DZ.
MAHAKE%^;+XX&@X_&-'XC6_''0%U\-_0.E;\25_RC0W<BA=Q!GI 6NK.NS8=8
M-U;#VS+A-]'_?N5_&]L)&SZ&YNBM@,-F+/MN)1[S2KSV*%O@C'Z'<=[8'MGP
M ;6+LFD@[[T^-[8;-GP4,;[_<,/8CN-WC,I,NQV&R46_?SPWMB<V?" MT-&!
M',&Y=9[/QK[9'VE@WBI--74PT0,5;65GI$J%$EJ5E99T@I+;[6!^MQ3*:34I
MLSFQ;O219^)-].^M%5R3YA]C]?:;;J<=D35I_F&9/GF'I+;=SB?2HZP:W(F-
M?;\-'YX!!-4.EB!AWNSD;>R;;?C _/G?_OKZY<M?S."LTND):.,])K] PZ<'
M,<W)13KY0A1,P.!7_&8\C>U5HL@8N'S",57@<IQ+[!2)$9WKXD3T&EMQFD9R
M9<*J-HJ"B@E']<.<2%Z]58[($46HIU-1R]:.5/V&EI]C"<+FPMI)3()3E->F
MS_!R4<%U-+%95:;G<8FTW%M9MLU:'M[OB&"#:7LH"+SUK%IL V$(CMI;Y"&"
M>G<AP6JFX$#-3NYBTZYHZWF>K+@+LZLTWR9K4F/DX019*"1&0FX0EIB/O8<4
MPA;R\LW3I]%\9[83;0F4(MI#MADS?;=)BIPR9M$L2TA&O?&7^%#U"+P6^C,C
MB2@["GH0ZNRT?E^=HEY1!EV&\I%PC1HOG/539-R$J8ZS8IO>VE)O6I5CGHM6
MHZ6LKP-ACI(&]#Q]&*7,@FQ12$B5?4%&8+MZD&DFV@*WGL1=3J>F28*<BJ9%
M?FYZ'?FD7(]HP<EJD<8DO) '\[G&].:62]/+A&T VE'J"Z:MNO4MHWN]I)FN
MPDF\L%*]LF1DP-^V2A+?+UD:H">.HSUSZ^'!R>"'0DR\_B4:X?G.N*G[P"?7
M BAN!%!L/M%%.+M_WAV]_0P0YI\_C#_N__K_4$L#!!0    ( "Z#5US,%0+5
M+DL  !O* 0 )    97@T+3$N:'1M[7UY;]M8EN__ O0=^ H]#>F!<66IJNE*
MT@%D6TXTS[$]ME+IH-$84!)EL4*1:I*RH_GT[VQW)2D[5<[B1(V9[M@F+^]R
M[MG/[SQ_-7Y]_*+;>?YJ.#B$_PWP/\_'H_'Q\,7S'_E_X:\_RI^?[Y\>O@LN
MQN^.AW__89YGU=/@T<-5%8R395P&)_%U<)XOHRSD7X3!15PD\Q_@17CU[&/?
M>Q8LH^(RR9X&^*C^_Q]>_#6;E*MGSW\\\P:NX@_5@RA-+N&5(KE<5,^"/_VM
MY_LOAA\6R22I@I_V'CW_<?]%_;M__B-'IR=C>[0'\VB9I)NG-XU'SY;)_\;\
M>;,U..#=S_198&_Q[^NR2N:;NYS^R7 T?C4\[W;&KT87P<7PX,WY:/PN.#D]
M#^#WZA>CX45P!+]Z^VIT\"IP'X5_#_\Q/#\870SVCX?!J\%OPV!_.#P)SH<O
M1Q?CX?GP,'@+'_''&YP<PHL'KP8G+X?!P>GKUZ.+B]'I2;=3_[3Y:W!Z!"_B
MA1B,A\$(/W(\&IP<#(,W9_#7P0G.Y?79&!\].C]]+9,X']!OWIP<#FN##P[&
M..JC7Y\\"8,!_/QZ"(\==CL]?/"OZ>S?Z_R9^_Q?"_IE/\1%P'\=')R>'XY.
M7AZ_"X/7 ]R],6P!C'I$JX<%79P>TVJ'9^/@[,WYQ9L!G-_XE"8,3QV,1[!K
MSEQIA3"5<;?3/NUS?[#!;X/1,9V#NP\A/@O;-0A@_),+>!G_@O.\>+/_7_!]
M>#^D3SB3.!_^]YO1.4WC @[FJ&D2>(XX,FT"'06=]N#L['AT0%/AP[)>.QZ\
MO=CSR B'\4:'(W]# ]#9"I$-91[VN[CGL-]GQ\/#ET.:S<'IR<F0%\FS"?9/
M3P;!T>AP"$^?OY0)OSFA33S%*Q <G\(&TI@PQC[0V!N@=3.=/6M[\%B[G5=P
MJ/!>;3KP[FB,FX/'33L"PP]/CX!27IX/86'C5X,Q/ )3.S[F0Q@>'X=\-$<X
MXCD0XL7HY8DW<..E['9N<2O_&.G!-OXV/ ?"KL_#'TE16[?S$=<.SYSV_BV<
M*]X]W"<XFK/ST]_@I XU45BLI&W3W:V%36G>VU!V-A1JP;6\>G>&LSA *G4'
M19XW",Y@#TX/\9.G)W"6L!R<R'#T\A4\<CAXA\=P?'SZEC=J"+\:#WF"0*RP
M4<#C<'DX0=K5WN'P:'2"1#:$M_J\A>]P;"9$6,-)T!OU:;"SX\$!OS9X.61R
M'>":X.!@A,/AX'AXWD3Q^"XQ()A52$RU-X(A[8L ?QX=X):<#<[')T)W\#O@
MJ+P 8(7G<(=A\,'9:#PX5@]>A,'Q\0'='&''>%4:9NK-<^_>BLE[+N61JN%*
M#,[/\<H"A>/%L/G#&5#X.1+B/WFE_-__"H/'#Q__LA?\=CJ"RW@$-S#X^>G#
MA\'9WNN],!@.\$X"DQJ]'H8-;SYYM#OPVTQ_&F=57-SE[$&'UK>QVZ'K^->B
M)$4FT Q)R($U[/NX3AF]*J*LG.?%\FFP7JWB8AJ5,6V!.L-O=7V#R3J;)5&W
M\S+-)U$:C):K:%H%+XM\O0J#43;=^W;7WGZV8V)H!R#U+\X&!R#]_O[#PQ_H
MY[/!X:'Z^:/WX#J950M\].%_/ LF>3&+BP?3/$VC50E35O_Z@2SZY^/SC__
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M!,P&D5> >G PN MR^V_AV(<1,,'4QD9@#XV(4(,%XCL*YCH#YU-PO):D41<
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M B:F:IMR'_OI6LUZITX=[@LP6+F>\.Z5M[&T*/P0!2DFLA4UC3H40+!IOIR
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M@ZA<-"0,:U>*>"AL[X5DQ K\M<(_46@$)15GL-0J])PB6]S[L1&'I?@):2C
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MA0%FMYRGA@C_Q'1XX^9V.YK_VE?86KA:K#8H3<9RDK*S4IP\A,>1^&4"NN9
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M(Y'-+(^G+4T*ZQGJU-PJ:7;WZYXL*Z/[]2JF<BS;ZEG(KS#_VN QVHJ$TAR
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M*I45R11>%M6JP>DW%W&4-/#T,FI@4_$5,&-^!'^> K%'^+MR&LZ]\V)X2UG
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M2*YG-?![%$&4:^NXLX+$U0+C3& :D1\)A;&3E]MZ6,25>=L57)7 4D<3W3Q
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M-+U\*GJK>UR-6V@S' 29(\&0 AUP6]@!O6LT-+("0&''V#ZL5_9 +T6&*88
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M(38A(<*Y\>E5U#IO8U(NZB7F1C#XE).HB@EUR2Z<JZW#H#YH<0 D(]O!B+[
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M-H@\'LX&M3:'O+&RJ>A<\KRZU'U$X-97>&W:.XZ;F'W$OB3D_B]2<9MP8I4
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MGT;]T=YRM=A*3):1<=<J6W1%8R>7K+O:",?'EM;;[59A56\"L  AH+ R]XX
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M9N8(V#U#'C)_3H%=55Z^B;C)0QXO-SN.QS3?A!2<5A-/78I),"B #G_6CTA
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MW #@4VLHUK3MT,_&PN_(Z.=F_P902P,$%     @ +H-77#9SA+\8#@  K3D
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M/8,_><_@1W;]6X&^HC^W#']_27^F^3]02P,$%     @ +H-77$EED!OT#
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M[:C3_20)B&C5H4NX71;><Z%P8"H>^DL87KA20G\\\LQ_?CFROUYVQ[US;0/
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M+UP>GN>WOD<CIFK"T)\SW7%1+B4@)Z#R)AC<XPB&:X\=/&[;\74N$O1!HIG
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M^'OHCO3&_P-02P$"% ,4    "  N@U=<V4N#[2T#  #Q"P  $0
M    @ $     86=I9RTR,#(V,#(Q.2YX<V102P$"% ,4    "  N@U=<F&0V
M[OT*  !_A@  %0              @ %< P  86=I9RTR,#(V,#(Q.5]L86(N
M>&UL4$L! A0#%     @ +H-77/F&GV=?!P  WE<  !4              ( !
MC X  &%G:6<M,C R-C R,3E?<')E+GAM;%!+ 0(4 Q0    ( "Z#5US1< GP
M-RX   T- 0 *              "  1X6  !E>#$P+3$N:'1M4$L! A0#%
M  @ +H-77-9LZL'GE   <GP#  H              ( !?40  &5X,3 M,BYH
M=&U02P$"% ,4    "  N@U=<S!4"U2Y+   ;R@$ "0              @ &,
MV0  97@T+3$N:'1M4$L! A0#%     @ +H-77-$$"3CQ00  ::D!  D
M         ( !X20! &5X-"TR+FAT;5!+ 0(4 Q0    ( "Z#5UPJ%I6U<@H
M '4F   )              "  ?EF 0!E>#4M,2YH=&U02P$"% ,4    "  N
M@U=<-G.$OQ@.  "M.0  "@              @ &2<0$ 97@Y.2TQ+FAT;5!+
M 0(4 Q0    ( "Z#5UQ)99 ;] P  $(^   *              "  =)_ 0!E
M>#DY+3(N:'1M4$L! A0#%     @ +H-77+A V';[&P  (-@   L
K     ( ![HP! &9O<FTX+6LN:'1M4$L%!@     +  L @P(  !*I 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="agig-20260219.xsd" xlink:type="simple"/>
    <context id="AsOf2026-02-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001156041</identifier>
        </entity>
        <period>
            <startDate>2026-02-19</startDate>
            <endDate>2026-02-19</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="AsOf2026-02-19" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2026-02-19" id="Fact000004">0001156041</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2026-02-19" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2026-02-19" id="Fact000010">2026-02-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2026-02-19" id="Fact000011">ABUNDIA GLOBAL IMPACT GROUP, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2026-02-19" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2026-02-19" id="Fact000013">1-32955</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2026-02-19" id="Fact000014">76-0675953</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2026-02-19" id="Fact000015">1300 Post Oak Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2026-02-19" id="Fact000016">Suite 1305</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2026-02-19" id="Fact000017">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2026-02-19" id="Fact000018">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2026-02-19" id="Fact000019">77056</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2026-02-19" id="Fact000020">713</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2026-02-19" id="Fact000021">322-8818</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2026-02-19" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2026-02-19" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2026-02-19" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2026-02-19" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2026-02-19" id="Fact000026">Common     Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2026-02-19" id="Fact000027">AGIG</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2026-02-19" id="Fact000028">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2026-02-19" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
